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ABSTRACT
HOUSE MAST CELL PROTEASES:
INDUCTION, MOLECULAR CLONING, AND CHARACTERIZATION
By
Wei Chu
Tryptase, a mast cell-specific serine protease with
trypsin-like specificity, has been identified in a mouse
mast cell line (ABFTL-6) based on it's enzymatic activity,
inhibition properties, and cross-reactivity to a human mast
cell tryptase antibody.
The effects of fibroblast-conditioned medium and sodium
butyrate on ABFTL-6 mast cell differentiation and tryptase
expression have been examined. ABFTL-6 mouse mast cells
undergo phenotypic changes upon culturing in media
supplemented with fibroblast-conditioned media at 50% or 1
mM sodium butyrate. The induced cells increased in size,
had larger and more metachromatic cytoplasmic granules, and
increased their total cellular protein about four-fold.
Tryptase activity increased 13- and 6-fold upon fibroblastconditioned media and butyrate induction, respectively.
However, tryptase antigen levels increased dramatically from
2.3 jxg/106 uninduced cells to 125 (54-fold) and 75 (33-fold)
/ig/10* cells induced with fibroblast-conditioned media or
butyrate, respectively.
A cDNA library was constructed in JLgtlO from ABFTL-6
cell poly (A)+ RNA, and screened with dog mast cell tryptase
and rat mast cell chymase cDNAs. Clones encoding two
distinct tryptases (mouse tryptases I and II), a chymase
(mouse chymase I) and a novel carboxyl terminal chymase
(mouse chymase II) were isolated and sequenced.
Mouse tryptases I and II have 75% and 70% sequence
identity at the nucleotide and amino acid levels,
respectively. The deduced amino acid sequence for the
mature active enzyme for each mouse tryptase contains 245
residues and all the characteristics of a serine protease.
Asp is found in the substrate binding pockets, consistent
with a trypsin-like specificity for Arg-X and Lys-X bonds.
It is predicted that tryptases are synthesized with
prepropeptides, requiring signal peptidase processing and
removal of a three amino acid propeptide for activation.
Mouse chymase I consists of a 226 amino acid catalytic
portion and a 21 amino acid preprosequence. An Asn occurs
in the substrate binding pocket, a feature that has not been
observed in any other serine protease.
iii
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CHAPTER 1
Introduction

Mast cells are wildly distributed throughout the
mammalian body, predominantly at the host-environment
interfaces such as the skin, respiratory tract and
gastrointestinal systems.

Mast cells appe&r primarily in

the mucosa and loose connective tissues.

Here they are

situated most often in the vicinity of blood and lymphatic
vessels, near or within peripheral nerves, and beneath
epithelial surfaces that are exposed to environmental
antigens (Selye, 1965; Metcalfe et al., 1981; Bienenstock et
al., 1989).

Mast cells are best known for their roles in

the IgE-dependent immediate hypersensitivity reactions and
the defense against parasitic infection.

However, recent

studies have revealed a considerably greater complexity of
mast cell biological function than previously had been
believed to exist (Galli, 1990).

Although the precise roles

of mast cells in health and disease are not fully
understood, they are believed to have important functions in
a variety of biological processes.

These processes include

delayed hypersensitivity (Askenase and van Loveren, 1983),
cytotoxicity (Farram and Nelson, 1980; Henderson et al.,
1981; Ghiara et al., 1985; Capron et al., 1978), immunoregulation (Beer and Rocklin, 1984), fibrosis (Broide et
al., 1990), and inflammation (Kaliner and Lemanske, 1984).
1

Local or systemic increases in mast cell numbers have been
identified in tissues in a variety of clinical situations
including inflammation, parasitic infestations (Befus and
Bienenstock, 1979), rheumatoid arthritis (Athreya et al.,
1979), lymphoproliferative syndromes (Yoo et al., 1978),
inflammatory bowel disease {Kirsner and Shorter, 1982), and
atopic dermatitis (Mimh et al., 1976).
Mast cells are immunoglobulin (Ig) E receptor-bearing
cells.

The cross-linkage of these high affinity receptors,

which results in mast cell degranulation, is central to the
induction of allergic inflammatory responses.

However, mast

cells can be induced to release their cytoplasmic granules
by a wide variety of stimuli (Lagunoff and Chi, 1980).

Some

of these mast cell secretagogues are schematically
summarized in Figure 1.

Sensitivity to many of these

secretagogues varies greatly depending on the mast cell
type.

Also, the extent and nature of mast cell granule

components released may vary according to the type and
concentration of stimulus, reflecting differences in mast
cell activation mechanisms and the potential roles of these
cells in biological processes not involving Ig E.

Thus, the

common assumption that mast cell activation is an "allergic"
or IgE-dependent event is far too restrictive.
Upon activation, mast cells secrete a variety of
preformed, biologically-active mediators stored in
cytoplasmic granules.

These mediators include histamine,

3
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I
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pressure

Degranulation

Figure 1.

Schematic illustration of selected mast cell

secretagogues.

This figure was adopted with modifications

from Friedman and Kaliner (1987).

proteoglycans, serine proteases, and many chemotactic
factors.

In addition, stimulated cells can synthesize and

release metabolites of arachidonic acid, such as
prostaglandins and leukotrienes.

Activated mast cells also

increase messenger RNA (mRNA) synthesis and secretion for a
group of lymphokines including interleukin-3 (IL-3)

(a mast

cell growth factor), IL-4 (an IgE-switch factor), IL-5 (an
eosinophil differentiation factor) and IL-6 (a factor
controlling immunoglobulin secretion)

(Plaut et al., 1989).

These peptide factors may account for much of the
inflammatory reaction and the late phase allergic reaction.
They may also participate in the regulation of the mast
cell's own proliferation and phenotype, especially during
immunological and pathological processes.

Furthermore,

several laboratories have provided evidence for the presence
of tumor necrosis factor a-like activities in mast cells.
For example, mast cell cytotoxity and the ability to induce
endothelial cell production of endothelial-leukocyte
adhesion molecule 1 have been attributed to tumor necrosis
factor a located in mast cell granules (Jadus et al., 1986;
Okuno et al., 1986; Klein et al., 1989).

These findings may

aid in explaining the roles of mast cells in a wide range of
tissue responses since tumor necrosis factor a has a number
of biological effects.

These include stimulation of

collagenase and prostaglandin E2 production, stimulation of
osteoclasts and bone resorption, and enhancement of

eosinophil toxicity (Vilcek et al., 1986; Capron et al.,
1978).
The discovery of mast cells is attributed to Paul
Ehrlich (1878) who first identified mast cells in human
connective tissues on the bases of the metachromatic
staining properties of their prominent cytoplasmic granules.
Because of the large granules, the cells were originally
thought to be phagocytic and given the name "mast" which in
German means "to eat".

In the century since their

discovery, considerable effort has been devoted to
understanding the biology and function of mast cells.
Recently, breakthroughs have made possible new and more
definitive approaches for analyzing the development and
regulation of mast cell phenotypes and for studying mast
cell functions.

One important achievement was the

establishment of the mast cell- and hemopoietic stem celldeficient mutant mouse strain WBBGFj-W/W7 (Kitamura et al.,
1978; Kitamura and Go, 1979; Geissler and Russell, 1983).

A

second major development was the generation of rodent mast
cells in vitro from hematopoietic tissues (Ginsburg, 1963;
Ginsburg and Lagunoff, 1967).

These advancements have

helped clarify many long-standing issues in mast cell
biology.
Hast Cell Heterogeneity. Differentiation and Origin
The regulation of mast-cell heterogeneity has attracted
wide-spread interest.

It is believed that mast cells of

different phenotypes may have different roles in health and
disease.

The initial observations that mast cells at

different histological locations exhibit distinctive
morphologies were made nearly 100 years ago.

Maximow (1905)

first noticed that certain mast cells in the rat intestinal
mucosa were atypical in their histochemical staining
characteristics, differing from mast cells located in other
tissues.

Beginning in the 1960s, EnerbSck (1966a, 1966b,

1966c, 1981) greatly extended these observations by
describing the distinctive properties of mast cells in
connective tissue and in the mucosa of the gastrointestinal
tract.

These results were confirmed by numerous

investigators (Bienenstock et al., 1982; Shanahan et al.,
1984; Barrett and Metcalfe, 1984).

There are two clearly

distinguishable populations of mast cells characterized in
rodents based principally on their location and their
different morphological, immunological, biochemical, and
functional properties (reviewed by Galli, 1990).

The terms

"mucosal mast cell" and "connective tissue-type mast cells"
(i.e., MMC and CTMC, respectively) are now the most widely
accepted designations for rodent mast cell subclasses.
heterogeneity of mast cells is best defined in the rat.

The
The

major phenotypic differences between these two rodent mast
cell subclasses are listed in Table 1,

In comparison with

the CTMC, the MMC are smaller, have fewer cytoplasmic
granules, possess a different serine protease composition,
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Table 1.

Phenotypic characteristics of mast cell
populations in the rat*

Characteristics

CTMC

MMC
4

Location

mucosa

skin, submucosa
connective tissue

Size

9.7 ± 2.2 pm

19.6 ± 2.7 pm

Granules

Few and small

Many and large

Proteoglycan

Lower sulfation,
chondroitin
sulfate £

Higher sulfation,
heparin

Serine protease

RMCP II

RMCP I

Histamine

< 1 pg/cell

> 15 pg/cell

Life span

£ 4 0 days

> 4 0 days
+

Histamine release
by compound 48/80
IL-3 dependency of
proliferation

+

Metachomasia with
formalin fixation

+

Staining with
safranin

+

Staining with
berberine sulfate

+

‘Adopted with modification from Bienenstock et al.,
(1982).
\

depend on IL-3 for proliferation, and are found most
prominently in the gastrointestinal tract.

In addition, MMC

contain chondroitin sulfate E glycosaminoglycans rather than
heparin and have a lower histamine content.

MMC are

nonresponsive to agents such as compound 48/80 and polymyxin
which degranulate CTMC.

Also, MMC differ histochemically

from CTMC in that MMC can be detected in tissue sections
only if acidified formaldehyde fixative or Carnoy's fixative
is used.

Both MMC and CTMC stain positive with alcian blue,

but only CTMC could be stained with safranin (EnerbSck,
1986).

Berberine sulfate, a fluorescent dye with an

affinity to heparin, has been used to distinguish CTMC from
MMC (Enerback, 1974).
Mammalian mast cells are known to be derived from
hematopoietic precursors which originated in the bone
marrow.

This was conclusively established in the mouse by

Kitamura et al. (1978).

They demonstrated that mast cell

deficient WBB6Ft-W/Wv mice can develop both CTMC and MMC
populations if they receive bone marrow cells from normal
donor mice.

In vitro studies also have confirmed their

hematopoietic origin.

Hasthorpe (1980) and others (Nagao et

al., 1981; Razin et al., 1981; Schrader, 1981; Tertian et
al., 1981) discovered that apparently pure mast cell
populations could be generated by culturing cells from
normal rodent hematopoietic tissues such as bone marrow,
spleen, lymph node, or fetal liver in media containing IL-3.

Nakano et al.

(1985) have shown that in vitro-cultured,

IL-3-dependent mouse bone marrow-derived mast cells (BMMC)
can give rise to both CTMC and MMC because both populations
are reconstituted in W/Wv mice by the transplantation of IL3-dependant BMMC.

This observation suggests that both MMC

and CTMC populations are derived from a common precursor
cell.
Human mast cells also exhibit variation in multiple
aspects of their phenotype, including the content of
granule-associated serine proteases, cytoplasmic granule
ultrastructure, histochemical properties, quantity of stored
histamine, and sensitivity to stimulation by various
secretogogues and drugs.

Like rat mast cells, human mast

cell subclasses also differ in serine protease content,
which distinguish human mast cell subclasses.

Some human

mast cells contain both tryptase and chymase (designated as
TC mast cells), whereas other human mast cells contain
tryptase but no detectable chymase (designated as T mast
cells)

(Irani et al., 1986).

TC and T mast cells appear

analogous in some respects, but not all, to rodent CTMC and
MMC, respectively.

Unlike rodent mast cells, human mast

cells can not be classified based on tissue location alone.
T mast cells predominate in the lung and small intestinal
mucosa; TC mast cells predominate in skin and small
intestinal submucosa.

However, these anatomical sites

10
contain representatives of both mast cell subtypes
(Schwartz, 1989).
Micro-environmental Regulation of Mast Cell
Development and Phenotype
It is well established that rodent mast cells could be
generated in vitro by culturing cells from hemopoietic
tissues in the presence of IL-3 (Nakahata et al., 1986).
These in vitro-derived. IL-3-dependent mast cells have been
cloned, and many cell lines have been established.

Thus,

these cells can be obtained in large quantities, providing a
good source of mast cells for a variety of biochemical and
functional studies.

This approach usually results in the

generation of basophils in humans rather than mast cells;
however, a recent report indicates that it is possible to
generate mast cell-like cells from human bone marrow under
certain culture conditions (Kirshenbaum et al., 1989).
Reasons for such difference among species are not clear.
These in vitro-differentiated, IL-3-dependent mast
cells are considered as the in vitro counterpart of the in
vivo-differentiated MMC, as assessed by ultrastructure,
histochemical staining, and IL-3 dependency for
proliferation.

Similar to MMC, mast cells derived from

hemopoietic tissues contain fewer granules which stain
alcian blue+/safrain‘, synthesis lower levels of histamine,
and chondroitin sulfate E proteoglycans rather than heparin
(sredni et al., 1983; Razin et al., 1982).

Moreover, rat

11
BMMC carry rat mast cell protease II {RMCP II) which is
specifically expressed in rat MMC (Haig et al., 1982, 19B6).
As discussed in the previous section, IL-3 dependent
BMMC populations whose phenotype resembles that of MMC give
rise to both CTMC and MMC populations in different
anatomical sites of W/Wv recipients.

This result suggests

that different mast cell subclasses are derived from cells
of a single lineage, and also that BMMC can undergo the
phenotypic change from MMC-like to CTMC; this was later
confirmed by biochemical characterization (Otsu et al.,
1987).

Similar findings were obtained with peritoneal mast

cells, a classical example of CTMC, which could give rise to
mast cells phenotypically similar to either the CTMC or MMC
(a CTMC

MMC-like change)

(Nakano et al., 1987).

Thus, it

appears that the tissue micro-environment determines the
phenotypic characteristics of mast cells.
In vitro it was demonstrated that by co-culturing with
a 3T3 fibroblast monolayer, BMMC could be induced to
differentiate and undergo phenotypic changes to resemble
CTMC.

The co-cultured mast cells increase their content of

cellular granules, which stain with safranin, raise their
histamine content 50-fold and carboxypeptidase A 100-fold,
and initiate the synthesis of heparin proteoglycans (LeviShaffer et al., 1986; Dayton et al., 1988).

Also, sodium

butyrate increases BMMC cytoplasmic granule-associated
serine protease levels 4-fold and histamine content 10-fold
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(DuBuske et al., 1984).

The sodium butyrate-treated mast

cells, however, remained alcian blue+/safranin', and did not
synthesize detectable quantities of heparin (Galli et al.,
1982).

Sodium butyrate is a pharmacologic agent that causes

hypermethylation and acetylation of cellular histones and
differential expression of mRNA (Riggs et al., 1977).
Dexamethasone has been found to have a similar effect on
BMMC (Pitton et al., 1988).
Xn vivo and in vitro studies have confirmed that mast
cells can change phenotype from "MMC
-+ MMC-like".

CTMC-like" and "CTMC

Recent evidence using cloned mast cell

populations indicate that at least some of these changes are
reversible (i.e. "MMC -* CTMC-like -* MMC» or "CTMC -♦ MMC-like
CTMC") upon changes of the micro-environment (Kanakura et
al., 1988).

It seems likely that T-lymphocyte factors (i.e.

IL-3) are needed to induce progenitor cells to differentiate
and proliferate along the mast cell lineage.

However, the

subsequent micro-environment which the mast cells settle
into determines their final phenotypic properties.

This

scheme is illustrated in Figure 2.
Mast Cell Granule-Associated Serine Proteases:
Trvotase and Chvmase
One characteristic feature of mast cells is the
presence of high levels of proteolytic enzymes in the
secretion granules.

These granules are known to contain

proteases with both trypsin-like and chymotrypsin-like
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Schematic diagram of rodent mast cell development

and differentiation,

circulating mast cells are derived

from precursor cells originating from bone marrow.

Further

differentiation of precursor cells into mature mast cells is
under the influence of the microenviroment where the
precursor cells settle.

The mature mast cells (CTMC and

MMC) are not end-staged cells and are able to undergo
further phenotypic changes if the tissue microenviroment or
culture conditions change.

specificities, referred to as tryptase and chymase,
respectively.
mast cells.

Both enzymes are exclusively expressed in
Tryptase and chymase are stored in fully active

form in association with acidic proteoglycans, mainly
heparin, within the cytoplasmic granules.

They are secreted

with other preformed mediators upon the coupled activationdegranulation response of mast cells (Schwartz et al.,
1981b; Caughey et al., 1988b).

This secretion process

differs from that for trypsin and chymotrypsin, which are
stored in pancreatic acinar cell granules as inactive
trypsinogen and chymotrypsinogen zymogens, respectively, and
are proteolytically activated after their release.
The serine proteases comprise a large group of enzymes
which are characterized by possessing a catalytic charge
relay system, including a reactive serine residue in the
active site.

They are also known as neutral protease since

they are most active in the physiological pH range.

The

distinguishing feature of these enzymes is their
susceptibility to inhibition by interaction of the active
site serine with diisopropylfluorophosphate (DFP).

This

group of enzymes (represented by trypsin, chymotrypsin, and
elastase) are classified as endopeptidases and cleave
peptide bonds on the carboxyl side of preferred amino acid
residues which define the enzyme’s substrate specificity.
Benditt and Arase (1959) first detected a protease with
a chymotryptic activity, now called RMCP I, in CTMC isolated

from the peritoneal cavity of rats.

Later, a second

chymotryptic protease designated as RMCP IX was localized
exclusively in rat MMC (Woodbury et al., 1978).

RMCP I and

RMCP II have substantial amino acid sequence homology with
one another (Benfey et al., 1987; Woodbury et al., 1978) but
are distinct gene products that can be distinguished from
one another with polyclonal antibodies.

A complementary DNA

(cDNA) that encodes RMCP II and its corresponding genomic
clone have been isolated (Benfey et al., 1987).

This work

also provided evidence that RMCP II is synthesized as a
precursor molecule, with an amino terminus signal peptide
and additional residues at the carboxyl terminus.
Mast cell chymases from several other species,
including mouse (Le Trong et al., 1989), dog (Caughey et
al., 1988b; Schechter et al., 1988), sheep (Huntley et al.,
1986), and human (Schechter et al., 1983, 1986; Wintroub et
al., 1986; Sayama et al., 1987), have been isolated and
partially characterized.
Glenner and Cohen (i960) first discovered high levels
of intracellular tryptic activity in mast cells by enzyme
histochemical staining.

Since then, similar enzymes have

been isolated and characterized from human (Schwartz et al,,
1981a; Smith et al., 1984; Cromlish et al., 1987; Harvima et
al., 1988; Butterfield et al., 1990), dog (Caughey et al.,
1987; schechter et al., 1988) and rat (Kido et al., 1985)
mast cells or mast cell-rich tissues.

While chymase is the

major granule-associated serine protease of rat mast cells,
tryptase seems to be the predominant protein component of
human mast cells.

Tryptase is estimated to comprise as much

as 23% of mast cell total protein (Schwartz et al., 1981b).
Tryptase polypeptides appear heterogenous on SDSpolyacrylamide gel electrophoresis (SDS-PAGE) with two major
bands of Hr = 30,900 and 31,600 (smith et al., 1984).

The

active enzymes appear to exist as tetramers of subunits with
a Mr = 135,000 (Schwartz et al., 1981a; Cromlish et al.,
1987; Caughey et al., 1987; Harvima et al., 1988; Kido et
al., 1988).

The observed electrophoretic heterogeneity

seems to be due in part to differences in glycosylation
(Cromlish et al., 1987), but differences in primary
structure can not be ruled out.

The recent report of

multiple tryptase cDNAs in human mast cells supports the
latter hypothesis.

Functional heterogeneity has been

observed regarding the specificities of human lung and skin
tryptases toward synthetic substrates (Tanaka et al., 1983).
Tryptase is stabilized and possibly regulated by the binding
of heparin which also resides in secretory granules.

The

affinity of human mast cell tryptase for heparin has been
used as a purification step (Schwartz et al., 1981a) and
differences in this property were used to partially separate
the two predominant forms of human lung tryptase (Smith et
al., 1984).

Tryptase has a trypsin-like substrate specificity, and
therefore hydrolyses peptide bonds on the carboxyl terminal
side of the basic residues Arg and Lys.

But unlike trypsin,

tryptase has a marked subsite preference and a
correspondingly high degree of substrate selectivity (Tanaka
et al., 1983).

These enzymes seem to make only selective

cleavages in protein substrates and have little if any
activity against denatured protein substrates such as
casein.

Another characteristic feature of human and dog

tryptases is resistance to inhibition by plasma serine
protease inhibitors, such as a-l-proteinase inhibitor (a-1Pl)

(Smith et al., 1984; Caughey et al., 1987; Alter et al.,

1990).

This feature may not be shared by rat mast cell

tryptase (Kido et al., 1985).

In rat, tryptase is

associated with and, therefore, may be regulated by an
endogenous tryptase inhibitor, which has been called
trypstatin (Kido et al., 1985, 1988).
The presence of high levels of tryptase and chymase in
mast cells suggests that this enzyme must be an important
component of mast cell function.
tryptase remain to be defined.

The biological roles of
In vitro, human tryptase

cleaves C3 to generate biologically active C3a (Schwartz et
al., 1983), destroys high molecular weight kininogen (Maier
et al., 1983), and inactivates fibrinogen as a coagulable
substrate for thrombin (Schwartz et al., 1985).

Increased

numbers of mast cells have been found in arthritic joints

(Malone et al., 1986), and, because trypsin is known to
activate collagenase, it was suspected that tryptase might
also.

Although tryptase failed to activate very pure

preparations of procollagenase (Johnson and Cawston, 1985),
Gruber et al. (1988) reported findings to the contrary,
subsequently, it was found that tryptase activates
prostromalysin but not procollagenase and the stromalysin,
which is often a contaminant of procollagenase preparations
actually activates procollagenase to collagenase.

More

recent studies indicate that tryptase rapidly hydrolyzes
vasoactive intestinal peptide (Caughey et al., 1988a;
Franconi et al., 1989), a neuropeptide that relaxes airway
smooth muscle (Said, 1984), and calcitonin gene-related
peptide, which is a potent vasodilator and
bronchoconstrictor.

The latter findings may suggest a

possible role for tryptase in modulating the biological
effects of neuropeptides.
In vitro, chymase converts angiotensin I to angiotensin
XI (Wintroub et al., 1984) and cleaves and inactivates both
substance P and vasoactive intestinal peptide (Caughey et
al., 1988a).

Chymase is able to degrade type IV collagen

and basement membrane components at the dermal-epidermal
junction and facilitate separation of these cutaneous
regions (Briggaman et al., 1984; Sage et al., 1979).

In

addition, chymase inhibitors and antibodies against chymase
prevent histamine release from stimulated mast cells,
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suggesting that chymase may be involved in certain processes
triggering mast cell degranulation (Kido et al., 1988;
Dietze et al., 1990).
The first primary structure data of tryptase resulted
from the cloning and sequencing of a cDNA from a dog
mastocytoma cell line (Vanderslice et al., 1989).

This work

also resulted in the cloning of a related enzyme's cDNA,
termed dog mast cell protease, which is 53.4% homologous
with dog tryptase.

Both enzymes appear to share a novel

activation mode, requiring cleavage at a Gly residue prior
to the Ile-Val-Gly-Gly amino terminus normal for active
serine proteases.

Subsequently, a human tryptase cDNA,

which had 84% amino acid sequence identity with dog
tryptase, was isolated from lung mast cells (Miller et al.,
1989).

More recently, three different but highly related

tryptase cDNAs from human skin and a gene coding for one of
the skin tryptase cDNAs have been isolated and characterized
(Vanderslice et al., 1990).
Rat mast cell proteases I and IX are used as selective
markers for distinguishing rat CTMC and MMC populations,
respectively.

While most mast cell granule-associated

mediators can be produced by other cell types, the serine
proteases may represent constituents restricted to the mast
cells.

Thus, they may provide important insights into the

unique functions of these cells.

Also, elevated levels of

tryptase or chymase in serum or other biological fluids may
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serve as clinically useful indicators of mast cell
activation and degranulation.
Although little is known concerning mouse tryptase,
there have been several reports dealing with chymases in
mouse mast cells.

It has been shown that serine proteases

comprise the major protein components of mouse BMMC
secretory granules and four granule-associated, [3H] DFPbinding proteins, ranging in molecular weight from 27 to 31
KDa, were identified (Dubuske et al., 1984).

These proteins

were secreted along with other granule-associated mediators
during mast cell activation (Serafin et al., 1986).

The

first mouse mast cell protease isolated, a chymase
designated as mouse mast cell protease I (MMCP-l), was from
the small intestine of mice infected with Trichinella
spiralis.

Its amino acid sequence has been determined

(Newlands et al., 1987; Le Trong et al., 1989).

In

addition, a second chymase, designated as mouse mast cell
protease II (MMCP-2), has been identified, and its cDNA has
been cloned and characterized from Kirsten sarcoma virusimmortalized mouse mast cells (Serafin et al., 1990).
2 has 65% amino acid sequence identity to MMCP-l.

MMCP-

Similar

to RMCP II, cDNA sequence data predict that MMCP-2 is
synthesized as a preproenzyme which contains a 19-amino acid
hydrophobic signal peptide and a two-amino acid propeptide.
More recently, four additional distinct serine proteases
have been identified in mouse serosal mast cells, and their
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amino-terminal amino acid sequences have been reported
(Reynolds et al., 1990).

These data indicate that different

mouse mast cell subclasses can express various combinations
of at least six distinct serine proteases.
Preliminary data from enzymatic activity assays and
immuno-dot blot experiments indicated that mouse tongue and
lung tissues and the in vitro-derived ABFTL-6 mouse mast
cells contained tryptase-like enzyme (Pierce et al., 1985).
Positive immunological cross-reactions were observed with
antibodies to human mast cell tryptase, and both mouse
tissues and ABFTL-6 cell lysates were found to contain
tryptase activity (Chu and Smith, unpublished observations).
To gain insight into mast cell functions in health and
disease, it is important to understand the regulation of
mast cell development and differentiation.

It is also

necessary to clarify and understand the nature of the
granule-associated proteases.

In this study, a tryptase

activity in the ABFTL-6 mouse mast cell line has been
identified.

The effects of fibroblast-conditioned media

(FCM) and sodium butyrate on cell differentiation and
tryptase expression in the ABFTL-6 mast cells were examined.
In addition, cDNAs for two distinct tryptases and two
chymases from ABFTL-6 cells have been successfully cloned,
characterized, and sequenced.

This work should provide

reagents for studying the expression and regulation

of these enzyme classes.

Also, It is now possible to

explore the relationship(s) between the primary structures
and the unique properties of these important proteases in
mouse mast cells.

CHAPTER 2
Materials and Methods

MsltqKJLaJls
RFMX 1640; penicillin/streptomycin; sodium butyrate; 5bromo-4-chloro-3-indolyl phosphate (BCIP); CBZ-Lysthiobenzyl ester (Z-Lys-SBzl); tosyl-L-Lys-chloromethyl
ketone (TLCK); tosyl-L-Phe-chloromethyl ketone (TPCK); lima
bean trypsin inhibitor (LBTI); benzamidine; antipain;
phenyl-methanesulfonyl fluoride (PMSF); 5,5'-dithiobis(2nitrobenzonic acid)

(Nbs2) ; Tween-20; sodium dodecylsulfate

(SDS); Coomassie Brilliant Blue G-250; dithiothreitol (DTT);
N,N,N'/H ,-tetramethylethylenediamine (TEMED); Tris(hydroxymethyl) aminomethane (Tris); IJ-(N-morphoinol) ethane
sulfonic acid (MES); B-mercaptoethanol (BME); ribonuclease
(RNase) A; protease K; formamide; and ethidium bromide (EBr)
were purchased from Sigma Chemical Company.
Ethylenediaminetetraacetic acid (EDTA), ammonium sulfate,
urea, nitro BT, acrylamide, polyethylene glycol 8000 (PEG),
guanidine isothiocyanate (GTC), bovine serum albumin (BSA),
nitro blue tetrazolium (NBT), 4-(2-hydroxyethyl)-1piperazineethanesulfonic acid (HEPES), toluidine blue, and
safranin were purchased from Fisher Scientific.
Diisopropylfluorophosphate was a product of Aldrich Chemical
Company.

Bactoagar, bactotryptone, and yeast extract were

purchased from Difco Laboratories.
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Fetal bovine serum (FBS)

was obtained from GIBCO Laboratories.

[3H] diisopropyl-

fluorophosphate, deoxycytidine [a-3ZP] 5'-triphosphate, and
deoxyadenosine [a-3SS] 5'-triphosphate were purchased from
New England Nuclear.

Adenosine [y-32P] triphosphate was

obtained from 1CN Chemicals.

M13 reverse sequencing primer

(17-mer) and the cDNA synthesis kit were purchased from
Pharmacia.

Seguenase DNA sequencing kit was from United

States Biochemical Corporation.

Polynucleotide kinase from

T4, T4 DNA ligase, calf intestinal alkaline phosphatase
(CIAP), reverse transcriptase, and reagents for primer
extension were obtained from Promega.

The nick translation

reagent kit was purchased from Bethesda Research
Laboratories.

A random primer DNA labeling kit was

purchased from Boehringer Mannheim.

Lambda in vitro

packaging extract and predigested lambda gtio DNA/EcoRl
cloning kit were purchased from Stratagene.

Alkaline

phosphatase-conjugated goat anti-rabbit IgG was from BioRad.

Nitrocellulose membrane (sheet and disc, 0.22 micron)

was purchased from Schleicher and Schuell.

Agarose was

purchased from the Marine Colloids Division of the FMC
Corporation.

The prestained standards were products of

Diversified Biotech.
A mouse mast cell line, ABFTL-6, was a generous gift of
Dr. Jacalyn Pierce (National Institutes of Health, Bethesda,
M D).

A contact inhibited, Swiss-albino mouse embryo-derived

3T3 fibroblast cell line was obtained from American Type
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Culture Collection (ATCC # CCL 92).

A dog mast cell

tryptase cDNA clone and a rat mast cell protease XI cDNA
clone were kindly provided by Dr. Peter Vanderslice (Univ.
of Calif. San Francisco) and Dr. Philip Leder (Harvard
Medical School), respectively.

Mouse tryptase II

oligonucleotide was kindly synthesized by Dr. Kent Lohman
(Southwest Foundation for Biomedical Research, San Antonio,
TX).
Mouse tissue poly(A)+ RNAs, human tryptase, tryptase
antibody, and a-l-PI were provided by Dr. David Johnson.
Mouse genomic DNA and chicken a-tubulin cDNA were supplied
by Dr. Phillip Musich.
The composition of solutions and buffers used in this
study and their abbreviations are listed in Appendix I.
Methods
Growth of ABFTL-6 Mast Cells and 3T3 Cells
Both ABFTL-6 mouse mast cells and the 3T3 fibroblasts
were cultured in RPMI 1640 media supplemented with 10%
heated-inactivated FBS, 100 unit/ml penicillin and 100 jug/ml
streptomycin.

All cell cultures were maintained at 37°C in

a humidified atmosphere of 5% C02.
Preparation of FCM
After the 3T3 cells formed a confluent monolayer, the
culture supernatant was collected by centrifugation at 1,000
x g for ten minutes.

The cell-free supernatant was
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carefully aspirated off and used immediately as FCM in
ABFTL-6 cell induction experiments.

Then, fresh culture

media was added to the 3T3 cell culture flask to cover the
cell monolayer (i.e. 50 ml for a T-150 flask).

FCM was

prepared every other day for each culture.
Growth of Mast Cells in 3T3 FCM Supplemented Media
ABFTL-6 cells were grown to a density of 0.5-0.6 x 10fi
cells/ml.

Then, the normal culture media was replaced with

1:1 mixture of fresh RPMI 1640 media and 3T3 FCM.

This

.culture was maintained for up to 12 days with media being
changed every other day.

Cells stopped dividing in the

presence of 3T3 FCM.
Sodium Butvrate Treatment of Mast Cells
ABFTL-6 cells at 0.3-0.4 x 104 cells/ml, were treated
with sodium butyrate by diluting a 100 mM sodium butyrate
stock solution to a final concentration of 1 mM in fresh
culture media.

This culture was maintained for 4 days with

daily replacement of the butyrate-supplemented medium.
Histochemical Staining
For metachromatic staining, ABFTL-6 cells were
collected by centrifugation at 100 x g and washed with PBS
buffer once in a 1.5 ml microfuge tube.

The cells were

suspended in 300 pi of Zamboni fixative solution (Stefanini
et al., 1967) for 1-3 minutes, pelleted by centrifugation
and stained in 300 pi of 0.5% (w/v) tpluidine blue in 0.5 N
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HC1 for 30-60 minutes.

The stained cells were washed twice

with deionized water (dH20), smeared, and air dried on
microscope slides for microscopic examination.
Alcian blue staining with a safranin counterstain was
performed as described (Ishizaka et al., 1976).

The mast

cells1 pellets were smeared, air dried on microscope slides,
and stained for 5 minutes in 0.5% alcian blue in 0.3% acetic
acid.

After rinsing with dH2o, the cells were counter

stained with 0.1% safranin in 1% acetic acid for 5 minutes.
Preparation of Hast Cell Extracts
cultured cells were harvested by centrifugation at 100
x g for 5 minutes.

The cells were washed with phosphate-

buffered saline (PBS) and resuspended in an appropriate
volume (usually at 20 x 10s cells/ml) of 10 mM MES buffer,
pH 6.1, containing 2 M NaCl.

The cell suspension was frozen

immediately in a dry ice-ethanol bath, and the cells were
lysed by repeated thawing and freezing four times, resulting
in complete lysis as judged by trypan blue exclusion.

The

extract was clarified by centrifugation in a microfuge at
12,000 x g for 10 minutes to remove insoluble cell debris.
Determination of Protein Concentration
The protein concentration of the cell extract was
determined by the method of Bradford (1976).

Three ml of

Bradford reagent was added to 0.1 ml TBS buffer containing
10-50 )Ltl of cell extract and mixed by vortexing.

The
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absorbance at 595 nm was measured in a 1 ml cuvette against
a reagent blank prepared from 0.1 ml TBS buffer and 3 ml of
Bradford reagent.

Dilutions of a 1 mg/ml BSA solution,

prepared based on a 280 nm extinction coefficient for 1%
protein solution of 6.6, were used to construct a standard
curve to determine the protein concentration in unknown
samples.
Measurement of Enzymatic Activity
Tryptic activity was determined by hydrolysis of the
chromogenic substrate Z-Lys-SBzl.

one unit of activity was

defined as that amount of enzyme resulting in an absorbance
at 410 nm increase of one absorbance unit per minute when
the initial rate was linear.

Reactions were carried out at

room temperature in a 1 ml volume containing 10-50 (tl of
cell extract, 0.1 mM Z-Lys-SBzl, 0.65 mM DTNB, 0.15 M NaCl,
0.05% Brij-35, and 0.1 M HEPES, pH 7.5.

The rates of

absorbance increase were measured with a Beckman Model 35
Spectrophotometer.
Inhibition of Tryptic Activity Assay
The effects of various serine protease inhibitors on
the tryptic activity in the mast cell extracts were tested
by preincubating 10 fil of extract with each of the
inhibitors for 60 minutes at room temperature.

For protease

inhibitors TLCK (1 mg/ml), TPCK (1 mg/ml), benzamidine
(2 mM), and antipain (0.1 mg/ml), the preincubation volume

was 400 III; FMSF (2 mM), a-l-PI (0.1 mg/ml), DFP (2.7 mM),
and LBTI (o.l mg/ml) were preincubated in a volume of 100
/zl.

The concentration of inhibitors indicated in

parentheses were the final concentration in the
preincubation mixture.

The tryptic activity remaining after

a 60 minute preincubation period was measured by following
the hydrolysis of Z-Lys-SBzl in a 1 ml reaction as described
above.

Residual activity was expressed as a percentage of

similarly incubated controls containing the same amount of
cell lysate, but no inhibitors.

The control values were set

at 100% activity.
SBS^PoJLv_acgy_lamid e_G_eI_Ele ctrophore si s
Protein samples were precipitated with 20%
trichloroacetic acid (TCA) at 4°C for 30 minutes.

The

protein precipitate was collected by centrifugation for 15
minutes in a microfuge (12,000 x g) at 4°C, washed
sequentially with cold 10% TCA and twice with 100% acetone,
and air dried.

The protein pellets were resuspended in

25-50 fil sample buffer and boiled for 3 minutes to denature
proteins.

Electrophoresis was performed using a Bio-Rad

Model 360 slab gel electrophoresis apparatus and the amidiol
buffer system of Bury (1981).

Proteins were separated on a

10% SDS-polyacrylamide gel (acrylamide/bis : 19/1).
Electrophoresis was carried out at a constant current of
15 mA in the stacking gel and 20 mA through the resolving
gel until the bromphenol blue dye front ran off the bottom
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of the gel.

Following electrophoresis, gels were stained

with Coomassie Brilliant Blue G-250 by the method of Steck
et al. (1980) and destained with a solution containing
methanol, water, and acetic acid at a ratio of 5:5:1.
r3Hl DFP Labeling of Serine Proteases and Fluoroqraphv
Cell extracts equivalent to 0.7 x 106 cells were
incubated with 45 (id [3H] DFP in a volume of 200 fil for
60 minutes at 22°C.

The labeled proteins were then

precipitated with 20% TCA at 4°C for 30 minutes and prepared
for SDS-polyacrylamide gel electrophoresis (SDS-PAGE).
After electrophoresis, the gel was soaked in 1 M sodium
salicylate for 30 minutes and dried on Whatman 3 MM paper
under vacuum before autoradiographing at -70°C using Kodak
X-AR film.
In another experiment, the lysates were incubated with
an excess of TPCK, which is known to inhibit chymotrypsin,
but not trypsin, for 60 minutes prior to incubation with
[3H] DFP.

Thus, the binding of [3h ] DFP to chymotryptic

proteases was presumably blocked, resulting in the
preferential labeling of other serine proteases.
Immuno-dot and Western Blotting
Immuno-dot blots were accomplished as described by
Smith et al. (1989) using the Bio-Rad Bio-Dot 96 well
filtration apparatus.

Cell extracts were diluted, and an

amount of extract equivalent to a fixed number of cells was
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applied to a nitrocellulose membrane by gravity filtration.
Each well was then washed with 200 pil TBS by vacuum
filtration.

For Western blots, proteins separated by SDS-

PAGE were blotted onto a nitrocellulose membrane using a
Milliblot-SDS system (Millipore) according to the
manufacture's instruction.
The membranes were blocked with 3% BSA £w/v) in TBS for
4 hrs and incubated with a 500-fold dilution of a rabbit
antisera to human mast cell tryptase in TBS containing
3% BSA and 0.05% Tween-20, usually for overnight.

After

washing the membranes three times for 10 minutes each in TBS
containing 0.1% Tween-20, they were incubated for 6 hours
with a 2000-fold dilution of the alkaline phosphataseconjugated goat anti-rabbit IgG secondary antibody.

The

membranes were developed in carbonate buffer (0.1 M NaHC03,
1.0 mM MgCl2, pH 9.8) containing o.is mg/ml BCIF and 0.3
mg/ml NBT with gentle shaking.

After the appropriate

intensity of the color developed, the reaction was stopped
by rinsing the filter with water.
F o l v m 4—HNA Isolation
This is the first step for cDNA cloning of mouse mast
cell proteases.

The procedure for molecular cloning are

outlined in Figure 3.

Total RNA was isolated using the

G T C / C s d density gradient centrifugation method of Chirgwin
et al. (1979).

Frozen cell pellets of uninduced ABFTL-6

cells (1.7 x 10a cells) were suspended in 9 ml of 5.5 M GTC

Mast Cell Culture

I
Poly (A)+ mRNA Isolation

I

cDNA Library Construction
1

cDNA Library Hybridization
Screening for Tryptase
1

Recombinant DNA Isolation
and Characterization

I

DNA Subcloning

I

DNA S equencing

Figure 3.

Outline of the procedure for cloning the cDNA

for mouse mast cell tryptases and chymases.

Cultured ABFTL-

6 mast cells were used as the source for poly(A)+ RNA.

A

cDNA library was constructed in AgtlO from the ABFTL-6
poly(A)+ RNA and screened for tryptases or chymase by plaque
hybridization with dog tryptase or rat chymase cDNA as
probes, respectively.

The recombinant DNA of positive

clones was isolated and characterized by restriction
cleavage analysis.

The inserts and their restricted

subfragments were subcloned into pTZ19U plasmid for
sequencing.

buffer to lyse the cells, followed by passage though an 18
gauge needle (approximately 6 times) attached to,a 10 ml
syringe until the viscosity decreased due to shearing of the
DNA.

The lysate was centrifuged at 5000 x g for 10 minutes

at 4°C to remove cell debris, then one half of the
supernatant was layered over 2 ml of 5.7 M CsCl in each of
two 13 ml tubes.

The RNA was pelleted by centrifugation in

a Du Pont AH650 swinging bucket rotor for 24 hours at 35,000
rpm at 18°c.

After centrifugation, the liquid in each tube

was carefully removed by aspiration, followed by inversion
and draining on a paper towel for 5 minutes.

The RNA pellet

was redissolved in 2 ml solution containing 0.5 mM EDTA,
0.5% sodium lauryl sarcosinate, and 5% BME and extracted
sequentially with phenol/chloroform (1:1) and chloroform.
The RNA was precipitated twice with ethanol and stored at
-80°C as a dried pellet.
The poly (A)* RNA was purified from total RNA by two
cycles of chromatography on oligo(dT)-cellulose (Aviv and
Leder, 1972).

After washing sequentially with a 0.1 N

NaOH/5 mM EDTA solution and water, the oligo(dT)-column was
equilibrated with loading buffer (20 mM Tris-HCl pH 7.6, 0.5
M LiCl, 1 mM EDTA, 0.1 % sodium lauryl sarcosinate). The RNA
sample was dissolved in RNase-free HzO, heated at 65°C for
5 minutes, and mixed with one volume of twice-concentrated
loading buffer before application to the column.

Then, the

column was washed sequentially with loading buffer and low
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salt buffer (same as loading buffer except containing 0.1 M
NaCl instead of 0.5 M LiCl) until the absorbance at 260 nm
of the eluent reached zero with each buffer.

The poly(A)+

RNA was eluted with 10 mM Tris-HCl pH 7.6, 1 mM EDTA, 0.05%
SDS.

The low salt wash and the eluted poly(A)+ fractions

were combined and rechromatographed on the column.

After

elution, the poly(A)+ RNA containing fractions, based on the
absorbance at 280 nm, were ethanol precipitated.
cDNA Synthesis and Library Construction
Double-stranded cDNA was synthesized from the mouse
mast cell poly (A)+ RNA by the method of Gubler and Hoffman
(1983), and a cDNA library was constructed in AgtlO from the
cDNA as described by Hyunh et al. (1985).

The cDNA library

was prepared using the Pharmacia cDNA Synthesis Kit and the
Stratagene AgtlO Cloning Kit and Gigapack Packaging Extract;
the manufacturers' instructions were followed.
diagram for cDNA synthesis is shown in Figure 4.

A schematic
Briefly,

poly (A)+ RNA (4 fig) was primed with oligo <3(T)12.ie which was
extended with reverse transcriptase to synthesize the first
strand.

The RNA-cDNA duplex was partially hydrolyzed with

RNase H, and the resulting nicked RNA was used to prime
second-strand synthesis employing E. coli DNA polymerase I.
The double-stranded cDNA mix was extracted with
phenol/chloroform, made blunt-ended by fill-in synthesis
with Klenow fragment DNA polymerase, and then size-selected
using a Sephacryl S-3 00 spin column with a 260 bp void
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Figure 4.

Schematic diagram of cDNA synthesis.

cDNA was

synthesized by the method of Gubler and Hoffman (1983),
using a cDNA synthesis kit from Pharmacia.
details.

See text for

exclusion limit.

Following attachment of an EcoRI/Notl

linker, the cDNA was phosphorylated with T4 polynucleotide
kinase and extracted with phenol/chloroform.

The free

linkers were removed using another Sephacryl S-300 spin
column.

Then the cDNA was ligated to EcoRI pre-cleaved,

undephosphorylated AgtlO DNA in a 5 |il reaction volume.

One

raicroliter of the ligation mix was packaged in vitro with
intact A phage particles, resulting in a cDNA library
containing 2 x 106 independent recombinants.

The titer of

the recombinant phage in the unamplified library was 4600
pfu//xl.
cDNA Library Screening
The unamplified cDNA library was screened by
hybridization of plaque lifts to a dog mast cell tryptase
(Vanderslice et al., 1989) or a rat chymase cDNA (Benfey et
al., 1987).

All probes were labeled with a3ZP-dCTP by the

random priming method (Feinberg and Vogelstein, 1984).

The

recombinant phage were propagated in Escherichia coli (E.
coli) C600 Hfl for first round screening to eliminate
background of wild type lambda phage, and in C600 for
subsequent screening,

one single colony of host cells from

a NZY agar plate was inoculated into SO ml TB broth
containing 0.2% maltose and 10 mM MgSO^.
incubated overnight with shaking at 37°C.

The culture was
The cells were

pelleted at 1,000 x g for 10 minutes and gently resuspended
in 10 ml of 10 mM MgSO^.

The library was initially screened

at a density of 2 X 104 plaques/ 150-mm plate.

Plaques were

lifted onto nitrocellulose filters, denatured in 0.5 N
NaOH/1.5 M NaCl and neutralized in 1 M Tris-HCl, pH 7.0, 1.5
M NaCl.

The filters were baked at 80°C for 30 minutes in a

vacuum oven.

Hybridizations at standard stringency were

carried out in 3 X s s c , 10 mM Tris-HCl (pH 7.4), 50%
formamide, 1% nonfat dry milk, and 0.1% SDS at 42°C for 1216 hours,

standard stringency hybridizations allowed for

29% mismatch with a probe containing 68% G + C (McCanaughy
et al., 1969).

After hybridization, the filters were washed

3 times for 30 minutes in 3 X SSC/0.1% SDS at 65°C.
Positive recombinants were detected by overnight
autoradiography at **70°C using Kodak XAR film with two Du
Pont Cronex Lightning Plus intensifying screens and isolated
by repeated cycles of plaque purification.

Recombinant

phage DNA was obtained as described below and slot-blotted
onto a Nytran membrane (Schleicher & Schuell) for further
hybridization analysis.

High stringency hybridizations were

carried out at 52°c in the same hybridization solution, with
a final post-hybridization, high stringency wash at 65°C for
30 min in 0.1 X SSC-0.1% SDS.

High stringency

hybridizations allowed for 7.6% mismatch.
Alcohol Precipitation of DNA
Alcohol precipitation was frequently used for recovery
and concentration of DNA or for removal of protein, salt,
and/or unincorporated nucleotides from DNA samples.

Either

ammonium acetate (5.0 M) was added to a final concentration
of 2-2.5 M or sodium acetate (3.0 M) was added to 0.3 M, and
then 2.5 volumes of 95% ethanol or 1 volume of isopropanol
were added.

If ethanol was employed, the solution was

chilled for 10 minutes in an ethanol-dry ice bath; whereas,
for isopropanol precipitation the solution was placed in an
ice-water bath for 10 minutes.

The DNA precipitate was

collected by centrifugation at 12,000 x g for 15 minutes at
room temperature in a microcentrifuge.

The DNA pellets were

rinsed with 70% ethanol and dried under vacuum.
DNA Isolation
Lambda DNA isolation.

E. coli strain C600 cells were

used as host cells for making a recombinant AgtlO phage
plate lysate for DNA isolation according to the method of
Verma (1989) with minor modifications.

Three hundred

microliters of competent cells were infected with 50,000
phage by incubating at 37°C for 30 minutes.

The infected

cells were mixed with 6 ml of top agarose at 48°C and plated
out on a 150-mm NZY agar plate.

The plates were incubated

at 37°C to obtain confluent lysis, usually requiring 6-8
hours.

Phage was eluted from the top agarose with 10 ml SM

buffer by shaking for two hours on an orbital shaker at room
temperature.

The lysate was pipetted off, and cleared by

centrifugation at 1,000 x g and then mixed with an equal
volume of saturated ammonium sulfate to precipitate the

phage.

The suspension was kept on ice for 20 minutes and

then centrifuged at 25,000 x g for 15 minutes at 4CC.

The

phage pellet was suspended in 0.5 ml of 3 M guanidine
isothiocyanate containing 2.5% sarkosyl and 10 mM EDTA, pH
7.5.

Protease K was added to a final concentration of 1.0

pg/pl and the solution was incubated at 52°C for 30 minutes.
The released phage DNA was alcohol precipitated and
suspended in 0.5 ml of T^E, buffer.

DNA was treated with

RNase A at a final concentration of 50 pg/pl for 20 minutes
at 37°C,

The DNA was extracted once with one volume of T10E1

buffer-saturated phenol/chloroform (1:1) and once with
chloroform.

After extraction, the DNA was alcohol

precipitated and resuspended in the appropriate volume of
T 1E 0.1*

Plasmid DNA minioreu.

Recombinant plasmid DNA was

isolated using a modified alkaline lysis method of Birnboim
and Doly (1979).

Cells from a transformed single colony

were inoculated into 20 ml LB broth with 50 pg/ml ampicillin
and grown overnight at 37°C with agitation.

Cultures were

centrifuged for 10 minutes at 1,000 x g at room temperature.
The cell pellets were resuspended by vortexing before adding
1.5 ml SET buffer, transferred to a 1.5 ml microfuge tube,
then pelleted by a 20-second spin in a microfuge.

The cell

pellet was vortexed until creamy and resuspended in 250 pi
SET buffer.

To lyse the cells and degrade the RNA

molecules, 0.5 ml freshly-prepared alkaline lysis solution

was added and the tube was gently inverted several times
then incubated at 65°C for 30 minutes.

Three hundred and

seventy microliters of 5 M potassium acetate, pH 4.8, was
added, and the solution was mixed and kept on ice for 20
minutes.

The precipitated material was removed from the

solution by centrifugation in a microfuge for 15 minutes' at
room temperature.

The plasmid DNA was precipitated by

adding 300 fil 27% PEG/3.3 M NaCl and incubating at 4°C for
two hours.

The DNA was collected by centrifugation for 15

minutes, rinsed with l ml 70% ethanol, and resuspended in
400 fil TE buffer.

After loading 8 jxl onto an assay agarose

gel, 400 (il 5 M NH^AC were added, and the DNA was
precipitated with isopropanol.
Agarose Gel Electrophoresis of DNA
Agarose gels were prepared in 50 mM TBE buffer with EBr
(0.5 jug/ml) at final agarose concentrations ranging between
0.7-1.8%, depending upon the size of the DNA fragments to be
separated.

The agarose was melted by boiling in buffer in a

microwave oven and allowed to cool to 65°C before being
poured into an appropriate mold with a well-forming comb.
DNA samples were mixed with 1/5 volume of SOG loading buffer
prior to loading.

Gels were electrophoresed in 50 mM TBE

buffer containing 0.5 Mg/ml EBr at constant voltage (50 or
loo volts) until the tracking dye reached the desired
position.

The DNA was visualized by uv-transillumination
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and photographed with Polaroid type 55 positive/negative or
type 667 high speed positive films.
DMA Restriction Enzvme Digestion
The restriction enzymes used in this study, their
recognition sequences, and their reaction buffers are listed
in Appendix XX.

The DMA subjected to restriction enzyme

digestion was diluted into the appropriate enzyme buffer.
Restriction enzyme was added at 1 unit//xg of DNA.

Nuclease-

free BSA and BME were added to all reactions at
concentrations of 100 ^g/ml and 6 mM, respectively.

The

samples were incubated at 37°C for 2-16 hours (65°C for
TaqI).
Electroelution of DNA Fragments
DNA restriction fragments were separated by
electrophoresis through an appropriate agarose gel.

The DNA

band of interest was located with long-wavelength
ultraviolet illumination.

A slice of agarose gel containing

the desired DNA fragment was excised with a razor blade and
placed into elution wells of an electroeluter (International
Biotechnologies, Inc.).

Then, 150 /il of 7.5 M ammonium

acetate/0.01% xylene cyanol solution was placed in the Vshaped channels of the electroeluter, and the DNA was eluted
from the gel at 50 volts for one hour in 1 X TAE buffer.
The eluted DNA in the ammonium acetate was recovered by
alcohol precipitation.
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Ligations
The pTZl9U plasmid vector DNA was digested with the
appropriate restriction enzyme to generate ends compatible
with those of the DNA fragment to be inserted.

The digested

vector DNA was treated with CIAP to remove the 5'-terminal
phosphates to prevent self-ligation.

The inserts of the

cDNA clones or their restriction enzyme fragments of
interest were mixed in about equal molar amounts (0.2 pmole)
with plasmid vector DNA.

The DNA mixture was heated at 65°C

for 5 minutes and brought up to a final volume of 10 pi in 1
X ligation buffer containing 1-2 units of T4 DNA ligase.
The reaction was incubated at room temperature for 30
minutes, and then at 16°c for 16 hours.
Bacterial Transformation
Transformations were carried out using a modified
procedure of Maniatis et al. (1982).

Competent cells were

prepared by growing E. coli (strain JM101 or MV1304) in LB
broth at 37°C to an OD60(J of 0.4-0.6.

The cells were chilled

on ice, collected by centrifugation at 5000 x g for 10
minutes, resuspended in 1/4 the culture volume of ice-cold,
sterile 0.1 M MgCl2, and allowed to stand on ice for 20
minutes.

After a second centrifugation at 5000 x g, the

cells were resuspended in 1/50 the original culture volume
of 50 mM CaCl2, and kept on ice for one hour.
Transformations were performed by adding 1-5 pi of ligation
mix to 100 pi of competent cells in a sterile, 13-ml glass

test tube and incubating on ice for a minimum of 30 minutes.
The transformation mixtures were heat-shocked at 42°C for
2.5 minutes and cooled to room temperature before adding 0.5
ml LB broth.

The cells were incubated at 37°c for 30

minutes with shaking; another 0.5 ml LB broth containing 100
/ig/ml ampicillin was added, and the incubation was continued
for another 30 minutes.

The cells were plated onto LB agar

plates containing 50 jil/ml ampicillin.

Only transformed

cells which obtained ampicillin resistance were able to grow
on these plates.
DMA Sequencing
DNA nucleotide sequences were compiled and analyzed
using the Hitachi DNASIS computer software (version 5.02).
Amino acid sequences were deduced from their cDNA and
analyzed using the Hitachi PROSXS software (version 5.02).
Denaturation of double-stranded DMA.

Double stranded

recombinant pTZ19U plasmid DNA (2-3 (ig), prepared by the
standard alkaline minipreparation procedure, was denatured
in 0.2 N NaOH for 5 minutes at room temperature.

The sample

•was neutralized by adding 0.4 volume of 5 H ammonium acetate
(pH 7.0), and then the DMA was precipitated with 4 volumes
of 95% ethanol at -45°c for 10 minutes.

After washing the

pelleted DNA with 70% ethanol and vacuum drying, the DNA was
redissolved in 7 |tl of dH20.

DNA dideoxvnuclaotide sequencing reactions.

All

nucleotide sequencing was performed by the dideoxynucleotide
sequencing method (Sanger et al., 1977) using the Sequenase
DNA sequencing kit according to the manufacture's protocols.
The denatured DNA (2-3 /ig) was primed with either M13
universal or reverse primer in a total volume of 10 til in
1 X Sequenase buffer.
was 1:1 (0.5 pmol).

The molar ratio of primer to template
The reaction was completed by

incubating the mixture at 65°C for 2 minutes, placing in a
beaker of 65°C water, and

allowing to cool slowly to room

temperature over a period

of 30 minutes.

DNA, 1 jtl of 0.1 H DTT, 2

til of labeling

mix (1.5 fiH of

dGTP, dCTP and dTTP), 0.5

/il of [35S)dATP

(10 ftC) , and 2 fil

of 1:8 diluted Sequenase were added.

To the annealed

The labeling reaction

was carried out at room temperature for 5 minutes before
aliquoting 3.5 jliI of the mix into a set of 4 tubes which
contained 2.5 fil of the appropriate termination mix
(containing 80 /iM deoxynucleotides and 8
appropriate di-deoxynucleotide).

of the

The termination reactions

were incubated at 37°C for 5 minutes and stopped by adding 4
fil of stop solution (95% form amide, 20 mM EDTA, 0.05%
bromophenol blue and 0.05% xylene cyanol FF).

The samples

were heated at 80°C for 2 minutes and chilled on ice just
before loading onto the assay gels.
DNA sequencing ael electrophoresis.

An IBI model STS
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sequencing gel electrophoresis.

The sequencing gels

contained 6-8% polyacrylamide (acrylamide/bis : 19/1) and
8.3 M urea in 50 mM TBE buffer.
filtered and vacuum degassed.

The gel solution was
Just before pouring, ammonium

persulfate and TEMED were added to 0.07% (w/v) and 0.03%
(v/v), respectively.

The gel solution was poured between

two glass plates with 0.4-0.8 mm wedge spacers and allowed
to polymerize for at least one hour.

The gel was pre-

electrophoresed at 1600 volts for a minimum of 30 minutes in
50 mM TBE buffer.

Aliquots of 3.5-6 jxl of each sequencing

mix were loaded into wells, and electrophoresis was
continued until the tracking dye had reached the desired
positions.

After the gel was soaked in 10% acetic acid-12%

methanol for 45 minutes to precipitate the DNA and to remove
the urea, it was then dried onto Whatman 3 MM paper at 80°C
and subjected to autoradiography.
Hybridization of Filter Bbnded DNA
Radioisotopic labeling of DNA probes.

Radioactive DNA

fragments were prepared for use as hybridization probes
either by random primer labeling (Feinberg and Vogelstein,
1984) or nick translation (Maniatis et al., 1982).

For both

methods, approximately 0.1-0.5 fig of DNA and either [a3aP]dATP or [a-32P]dCTP, as radioactive nucleotide, were used
in each labeling reaction.

For random primer labeling, the

DNA was denatured by heating for 10 minutes at 90°C and

subsequent cooling on ice.

A mixture of random sequence

hexadeoxynucleotides, all deoxynucleotides except the one
which was to be used in radioactive form, reaction buffer
(Promega), and 10 pci radioactive nucleotide were added.
The reaction was started by adding 2 units of Klenow enzyme,
and, after incubating at 37°C for 30 minutes, was stopped by
adding 2 pi of 0.2 M EDTA and heating to 65°C for 10
minutes.

Nick translation was done by diluting DNA into a

reaction mix containing nick translation buffer (Bethesda
Research Laboratories), deoxynucleotides, and about 10 pCi
radioactive nucleotide.

Labeling was started by the

addition of 2 units of DNA polymerase I and 0.2 ng of DNase
I; the reaction was incubated at 15°C for 60 minutes and
terminated by adding 0.5 M EDTA to 30 mM.

DNA labeled by

either procedure was precipitated twice with ethanol and
resuspended in an appropriated volume of hybridization
buffer.
The synthetic oligonucleotide probe was radiolabeled at
its 5'-terminus 37°C for 30 minutes with 166 pci [y -3zP]ATP.
A total volume of 15 pi of 1 X kinasing buffer containing
100 ng oligonucleotide and 8 units of T4 polynucleotide
kinase.
minutes.

Then, the enzyme was inactivated at 65°C for 5
The labeled oligonucleotide was ethanol

precipitated.
Slot-blotting of nucleic acids.

Slot-blotting was

performed by using a Bio-Rad 48 slot filtration apparatus.
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A DNA sample for slot-blotting was denatured in 0.2 N NaOH
at 65°C for 30 minutes and then neutralized with 3.5 volume
of 1 M Tris-HCl/2 M NaCl (pH 7.0).

Hybridization membranes

(either nitrocellulose or Nytran) were wetted sequentially
in dHz0, then 12 X SSC.

Aliquots of 20-200 fil of the DNA

solution were slotted onto the membrane by vacuum
filtration.

RNA samples were prepared in 6 X SSC/7%

formaldehyde and heated at 65°C for 15 minutes before
applying to a nitrocellulose membrane.

The NaOH-treated

control RNA samples were made in 0.2 N NaOH, heated at 65°C
for 30 minutes, and neutralized by adding 2 volumes of 1 M
Tris-HCl (pH 6.0).

The membranes were baked at 80°C for 30

minutes.
Southern and northern blotting.

Samples of mouse

genomic DNA were digested with several restriction
endonucleases.

After agarose gel electrophoresis to

separate the DNA fragments, the gel was stained in 50 mM TBE
buffer containing 0.5 jig/ml EBr for 15 minutes and
photographed using transmitted UV light.

The gel was then

soaked in 0.25 N HCl for 20 minutes, rinsed with dHzO, and
soaked in 0.4 N NaOH twice for 15 minutes each to denature
and cleave the DNA backbone at the acid-depurinated sites.
The gel was neutralized by soaking in 1 M Tris-HCl (pH 7.4)
for 20 minutes.

After a brief rinse with 10 X 5SPE, DNA in

the gel was transferred onto a nitrocellulose or Nytran
membrane with 10 X SSPE employing either a standard
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capillary blotting apparatus (Southern, 1975) or using a
VacuBlot apparatus (American Bionetics) according to
manufacture's directions.
Northern blotting was performed according to Maniatis
et al. (1982).
ethanol.

Poly(A) + RNA samples were precipitated with

After resuspending in dH2O f the RNA samples were

denatured for 15 minutes at 65°C in formaldehyde (2.2
M)/formamide (50%), loaded onto and electrophoresed in a 2.2
M formaldehyde-1.5% agarose gel.

The gel was soaked

sequentially in dHao and 20 X ssc and the RNA was
transferred to a nitrocellulose membrane by capillary
blotting.
Stripping probe from filters.

Previously hybridized

probes were stripped off Nytran membranes by boiling the
filter for 20 minutes in 0.01 X SSPE/0.5% SDS.

Probes bound

to nitrocellulose filters were stripped by two 20-minute
washes at 65°c in 50% formamide, 2 X SSC, and 0.5% non-fat
skin milk.

After stripping, the filters were rinsed in 2 X

SSPE or SSC and exposed to X-ray film to check for complete
removal of the probe.
Autoradioqraphv.

Membranes and gels containing 3ZP-

labeled DNA were sealed in plastic bags or cover with
plastic wrap, respectively, and directly exposed to Kodak
XAR-5 film with two Du Pont cronex Lightning Plus
intensifying screens at -85°c for several hours to three
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weeks.

Gels with 35S-labeled DNA were dried onto Whatman 3

KM paper before exposure to XAR-5 film at room temperature.
All films were developed up to 7 minutes in Kodak GBX
developer, fixed for 10 minutes in Kodak GBX Fixer, and then
rinsed in running water for 15 minutes before air drying.

CHAPTER 3
Results
Morphological changes of Mouse Hast Cells Induced with
FCM or Sodium Butvrate
ABFTL-6 cells contain a relatively low amount of small
cytoplasmic granules.

When the cells were cultured in the

media containing 50% FCM for 10 days or in the presence of 1
mM sodium butyrate for 4 days, the majority of the cells
increased in size as well as in cytoplasmic granulation.
The results shown in Figure 5 are representative of mast
cell populations in each category of a typical experiment.
The photographs were taken at the same magnification and at
random field positions of cells stained with either
toluidine blue or alcian blue.

By comparison to the

untreated mast cells {Panel A ) , the mast cells induced with
either FCM (Panel C) or butyrate {Panel B) significantly
increased their average cell volumes.

This increase in cell

size was evident after four days for FCM, or two days for
sodium butyrate treatment, respectively.

Also, the granules

were larger and were stained more intensely with the
metachromatic dye toluidine blue upon induction.
Effects of FCM and Sodium Butvrate Culture on
Mast Cell Trvotase Activity and Antigen Levels
Tryptic activity was identified in high salt extracts of the
mast cells by enzymatic assays using synthetic substrates.
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Figure 5.
Morphological
changes of
ABFTL-6 cells
induced by 3T3
FCM and by
sodium butyrate.
(A) Uninduced
control cells
stained with
toluidine blue.
(B) Cells were
grown for 4 days
in the media
containing 1 mM
sodium butyrate
and stained with
alcian blue,
(C) Cells were
grown for 10
days in the
media containing
50% FCM and
stained with
toluidine blue.
Photographs were
taken from
random fields of
stained slides
with Kodak
Ektachrome 50
slide film.
(Magnification
X576).

In order to clarify the tryptic activity identified in these
mast cells, several serine proteinase inhibitors were tested
for their effect on the observed tryptic activity.

A unique

biochemical property of mast cell tryptase, which
distinguishes it from other serine proteases (i.e.
pancreatic trypsin), is its resistance to trypsin inhibitors
such as a-1 protease inhibitor (a-l-PI) and lima bean
trypsin inhibitor (LBTI).

The inhibition profile obtained

is presented in Figure 6.
The tryptic activity was almost totally abolished by
the strong serine protease inhibitors PMSF and DFP, and
significantly inhibited by antipain and benzamidine.

An

irreversible chymotrypsin inhibitor that alkylates the
active site histidine TPCK, showed partial inhibition (40%).
A trypsin inhibitor with the same mechanism as TPCK, TLCK,
caused 77% inhibition.

It seems likely that some of the

tryptic activity in the cell extract may be due to
chymotryptic enzyme.

However, TPCK also partially inhibited

purified mast cell tryptases from human lung (70% activity),
and dog mastocytoma (80% activity)
Smith et al., 1984).

(Caughey et al., 1987;

TLCK had a similar effect on the

tryptase isolated from a human mast cell line (24% activity,
Butterfield et al., 1990).

Like other tryptases, this

activity was not affected by either a-l-PI or LBTI.
less susceptible to inhibition by benzamidine
(63% inhibition) than tryptases from human lung

It was

PMSF

20

40
60
% Activity

80
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Figure 6.

In vitro inhibition profile of mouse mast cell

tryptase.

A single lysate from FCM induced ABFTL-6 cells

was used for all inhibition studies.

The residual tryptic

activity presented was calculated relative to the control,
which contained no inhibitor (100% activity).
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(96.5% inhibition) and dog (95% inhibition).

However, the

tryptase isolated from human mast cells was more resistant
to benzamidine inhibition (20% activity).

The inhibition

profile in Figure 6 is similar to those of purified dog mast
cell tryptase and human tryptases, indicating that the
tryptase activity of the ABFTL-6 cells is due primarily to
similar tryptase(s).
Furthermore, a tryptase antigen was identified in the
ABFTL-6 cell extracts, which reacted with antibodies against
human mast cell tryptase.

Both immuno-dot and Western blots

analyses were positive and suggested structural similarities
between mouse and human tryptases (see Figure 8 and 9
below).

The evidences provided by the inhibition study and

the immuno-blotting analyses support the conclusion that the
ABFTL-6 tryptic activity was due to the mast cell tryptase.
Upon treatment with FCM or sodium butyrate, there was
an increase in total cellular protein (Figure 7).

Tryptase

activity and antigen levels in the cell extracts also
increased strikingly.

The mean of tryptic activity of

induced ABFTL-6 mast cells was 1.66 units/106 cells for the
FCM culture (n=5) and 0.82 units/106 cells for sodium
butyrate treatment (n=7)

(Table 2).

These levels were about

13- and 6-fold higher than the control level (0.13 units/106
cells, n=7) upon induction with FCM and sodium butyrate,
respectively.
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The effects of 3T3 FCM and sodium butyrate

treatment on tryptic activity and total cellular protein of
ABFTL-6 cells.

Data are presented as mean + SD of three

separate experiments, each carried out in duplicate.
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Figure 8.

i

Immuno-dot blot quantification of total tryptase

antigen in the induced and the uninduced ABFTL-6 mast cells.
Cell lysates were diluted and the amount of lysate
equivalent to a fixed number of cells (as indicated in the
right margin of the figure) was applied to each row of the
blot.

Human mast cell tryptase was used as standard and was

shown to the left of the figure.

A rabbit IgG against human

tryptase was used as the primary antibody.

The tryptase

antigen was detected by using goat anti-rabbit IgG-alkaline
phosphatase conjugate as a secondary antibody.
human mast cell tryptase standard.
culture of ABFTL-6 mast cells.

Panel B, 10-day FCM

Column B1 and B2 represent

different preparations of induced cells.
ABFTL-6 cells.

Panel A,

Panel C, uninduced
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Table 2.

The Effect of FCM and Sodium Butyrate on Tryptase
Expression in ABFTL-6 Mouse Mast Cells

Treatment1
FCM

Total Protein
(mg)

Butyrate

Control

0.33 ± 0.20
(n=5)

0.27 ± 0.13
(n=6)

0.09 ± 0.02
(n=5)

t
Tryptic
1.66 ± 0.39
Activity (unit)
(n=5)

0.82 ± 0.51
(n=7)

0.13 ± 0.08
(n=7)

Total Tryptase
Antigen2 (Mg)

125

Tryptase
Antigen to
Total Protein

38%

75

28%

2.3

2.7%

1 The data were expressed as the mean ± standard deviation
for 106 cells.

N is the number of individual cell

cultures measured.
2 Total tryptase antigen was calculated from the data in the
dot-blot immunoassay based on a standard of human
tryptase.

This determination was performed once.

Immuno-dot blots were used to quantify the tryptase
protein in cell extracts and to monitor the tryptase antigen
levels upon induction (Figure 8).

A data summary table of

tryptase induction of FCM and butyrate is shown in Table 2.
The value for tryptase concentration in cell extracts is a
relative value since purified human tryptase was used as the
standard under the assumption that mouse tryptase is 100%
reactive to human tryptase antibody.

Statistical analysis

(pared t test) revealed that the increases of both total
cellular protein and tryptic activity induced by FCM or
sodium butyrate are significant (p < 0.1).

Figure 9 shows a

Western blot analysis with an antibody against human
tryptase.

significant increases in tryptase antigens were

observed in both FCM and sodium butyrate treated cells; the
highest increase was found in the cells induced with FCM.
To check whether the increased tryptic activity was due to
the frequent media changes, the
performed.

following control was

ABFTL-6 cells were grown in unsupplemented media

which was replaced by fresh media when the media was changed
on the induced cells.

Cells were seeded at the same density

and maintained for the same length of time as the induced
cells.

There was no statistical difference between the

tryptic activity of these control cells and the starting
cells.

As seen in Figures 9 and 11, there was no

significant visual difference in the tryptase antigen level
between these cell populations and the starting cells.
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Figure 9.

Western blot analysis for tryptase antigen in

induced and uninduced ABFTL-6 mast cells.

The proteins in a

cell lysate equivalent to 0.7 x 106 cells were precipitated
by 20% TCA, resuspended, and separated by electrophoresis on
a 10% SDS-polyacrylamide gel.

The separated proteins were

electroblotted to a nitrocellulose membrane which was then
probed with an affinity-purified antibody against human
tryptase.

(A) Molecular weight standards;

(B) starting

ABFTL-6 cells; (CJ control ABFTL-6 cells for sodium butyrate
treatment; (D) sodium butyrate treated ABFTL-6 cells;

(E)

control ABFTL-6 cells for FCM treatment; (F) FCM induced
ABFTL-6 cells; (G) human mast cell tryptase.
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Figure 10.

Western blot analysis of sodium butyrate-

induced tryptase antigen in ABFTL-6 cell lysates.

Fifty

micrograms of lysate protein were precipitated by 20% TCA
and separated by electrophoresis on a 7.5% SDSpolyacrylamide gel and blotted to a nitrocellulose membrane.
Rabbit anti-human tryptase antibody and goat anti-rabbit IgG
antibody conjugated to alkaline phosphatase were used as
primary and secondary antibodies, respectively. (A) Lysate
of ABFTL-6 control cells; (B) lysate of ABFTL-6 cells grown
in 2 raM sodium butyrate for four days; (C) lysate of ABFTL-6
cells grown in 1 mM sodium butyrate for four days; (D) human
tryptase standard (l ug).
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The effect of different concentrations of sodium
butyrate on the induction of tryptase was examined.

As

shown in Figure 10, 1 mM butyrate-supplemented media induced
more tryptase expression than 2 mM butyrate-supplemented
media.

A notable feature of this blot is that the band in

lane C seems to contain two closely spaced bands, indicating
tryptase heterogeneity.
Both FCM and Sodium Butyrate Increased Total
DFP-Bindino Proteins
DFP is a strong serine protease inhibitor which is able
to irreversibly bind to the active site serine residue of
all serine proteases.

Figure 11 shows an autoradiograph of

[3H] DFP-labeled proteins from induced and uninduced ABFTL-6
mouse mast cells.

The cell extracts were incubated with an

excess of TPCK, a chymotrypsin inhibitor, before reaction
with [3H] DFP to abolish the possible binding of the [3H]
DFP to chymase.

Therefore, the bands observed in this

autoradiogram are most likely due to tryptases, but could
represent other serine proteases.

As shown in this figure,

the intensity of the bands corresponding to a Mr of 35 KDa
in sodium butyrate or FCM induced mast cells increased
significantly from those found in uninduced mast cells.

The

degree of the increases of "DFP-binding protein” is
comparable to the increases of tryptase antigen observed by
Western blot analysis (see Figure 9).

Some high molecular

weight bands were seen in some extract preparations.
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Autoradiography of gel fractionated [3H] DFP-

labeled proteins in ABFTL-6 cell lysates.

A lysate

equivalent to 0.7 x 106 cells of each cell sample was
incubated with excess [3H] DFP, as described in Materials
and Methods, and separated on a 10% SDS-polyacrylamide gel.
(A) The positions of the prestained standards were marked on
the dried gel with radioactive ink.
cell tryptase (1 ug).
butyrate.
treatment.

(C) ABFTL-6 cell grown in 1 mM sodium

(D) ABFTL-6 control cells for sodium butyrate
(E) 3T3 FCM induced ABFTL-6 cells.

control cells for 3T3 FCM treatment.
cells.

(B) Human lung mast

(F) ABFTL-6

(G) Starting ABFTL-6

Possibly, they are enzyme aggregates or non-specific DFPbinding proteins.

Differences in the molecular weight of

mouse tryptase observed between the Western blot and the
autoradiography of DFP-binding study were noticed.
Molecular Cloning of House Mast Cell Trvptases
The yield of total RNA isolation from ABFTL-6 cells was
2.8 /jig/106 cells.

The poly (A)* RNA was isolated from the

total RNA at 4.2% recovery rate.

A RNA slot blot

hybridization analysis was performed using RNA from ABFTL-6
cells to determine whether RNA homologous to the dog
tryptase cDNA exists in these mouse mast cells.

As shown in

Figure 12, RNA slot-blot hybridizations revealed that the
900 bp dog tryptase cDNA strongly hybridized under standard
stringency conditions to the poly(A)* RNA isolated from
ABFTL-6 cells, indicative of a high level of tryptase
expression in these cells.

The hybridization in the

poly(A)+ RNA fraction was due to RNA since there was no
apparent DNA contamination in that fraction, as evidenced by
the lack of hybridization in the corresponding NaOH-treated
RNA sample.

The NaOH treatment, which completely degrades

RNA, but not DNA, demonstrated that the positive result was
due to hybridization to RNA and not to contaminating DNA.
The strongest hybridization was found in the low salt wash
fraction which contains mostly short, poly(A)+-tailed RNA,
unable to bind tightly to the oligo(dT) column, suggesting
that most tryptase messengers only bear short poly(A)*

64

Figure 12.

Mouse mast cell RNA slot-blot hybridization

analysis for tryptase-encoding sequences.

Poly(A)+ RNA of

mouse mast cells was isolated by two cycles of oligo (dT)
cellulose chromatography.

The poly (A)+, low salt wash and

poly(A)' RNA fractions were collected and slot-blotted onto
a nitrocellulose membrane.

Hybridization was carried out at

standard conditions, with dog mast cell tryptase cDNA as
probe.

(A) Formaldehyde-denatured RNA; (B) NaOH-treated

RNA; (C) NaOH-treated mouse genomic DNA as control.
and 2 contain 1 and 3 /ig RNA, respectively.
contain 0.4 and 2 /ig of DNA, respectively.

Lane 1

Row a and b
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tails.

Only very faint bands were

seen in the denatured

mouse genomic DNA, suggesting the number of tryptase genes
may be small.
A cDNA library was constructed from the poly(A)+ RNA
isolated from mouse mast cells.

Initial screening of the

mouse mast cell cDNA library with the dog tryptase clone
yielded several hundred (0.5% frequency) hybridizationpositive plaques.

Twenty positive clones were arbitrarily

selected for further studies and were plaque purified prior
to isolating their DNA.

Digestion of the recombinant phage

DNAs with EcoRI released inserts that ranged in size from
950 to 1200 bp.

The isolated recombinant phage DNAs were

slot-blotted onto a nitrocellulose membrane for rescreening
with the dog tryptase cDNA probe under defined conditions.
These included highly stringent hybridization conditions
which allowed for approximately 7.6% mismatch.
made in duplicate.

The blot was

One was hybridized to dog tryptase DNA;

the other to lambda DNA to determine the relative amount of
recombinant vector DNA loaded in each slot.

Also included

were samples of the cDNAs for dog tryptase and RMCF II.
Figure 13 shows the autoradiograms of the DNA slot-blot
hybridization patterns under highly stringent conditions.
Although all the clones hybridized to dog tryptase cDNA at
the standard conditions (data not shown), some of them
hybridized poorly at highly stringent condition.

For

example, clone #4 6 and #24 had little hybridization
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Figure 13.

Hybridization analysis of DNA from tryptase-

positive clones by slot blotting.

DNA of tryptase-positive

lambda clones was isolated, denatured and slot-blotted onto
a nitrocellulose membrane at two different concentrations,
20 ng and 200 ng (based on ethidium bromide staining
intensity in agarose gels).

A and B are duplicate blots and

were hybridized at highly stringent conditions requiring
92.4% sequence complementary.
their left,

DNA samples are numbered at

Trp - dog tryptase cDNA, Chy - RMCP II cDNA.

(A) Blot hybridized with lambda DNA probe; (B) Blot
hybridized with dog tryptase cDNA probe.
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(Panel B ) , although they contained equivalent amounts of DNA
as judged from their hybridization to lambda DNA (Panel A ) .
The figure also shows that there was no cross-hybridization
between dog tryptase and RMCP II (chymase) cDNAs, or between
dog tryptase and lambda DNA.
Five clones (ATI, AT4, AT26, AT55 and AT85) showed
strong hybridization under these highly stringent
conditions,

clone AT86 hybridized less intensely, but

contained the longest insert.

The inserts in these six

clones were subcloned into pTZ19U plasmid and their
nucleotide sequences were determined.

The subcloning and

sequencing strategy are presented in Figure 14.

The

sequences obtained fell into two groups each of which coded
for a distinct tryptase.

The first group consisted of

clones pAT4, pATl and pAT86, designated as mouse tryptase I;
the second group contained pAT26, pAT55 and pAT85, and was
designated as mouse tryptase II.

clones pAT4 and pAT26 were

chosen as representatives of mouse tryptase I and tryptase
II, respectively.

These cDNAs were cleaved into

subfragments by PstI and Sau3A for subcloning in order to
obtain sequence data from both strands.
The cDNA's composite nucleotide sequence for mouse
tryptase I and its derived amino acid sequence are presented
in Figure 15.

Tryptase I cDNA is 1086 bp long, contains an

open reading frame of 822 bp, and a 3 '-noncoding region of
264 bp.

The putative sequence for the polyadenylation
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strategy used to subclone and sequence the cDNAs

for the mouse mast cell tryptases.

The rectangles represent

the open reading frames of the cDNA clones.

The hatched and

open areas show the regions encoding the putative
signal/activation peptide and the active tryptase,
respectively.

The intron found in clone p>,T86 is denoted as

a dotted box below the open reading frame.
designate the 3 '-noncoding region.

The thick lines

The thin lines with

arrows indicate the length and direction of nucleotide
sequences obtained by dideoxnucleotide sequencing of the
cDNAs and their subclones.

All sequence data was verified

by sequencing both strands of the cDNA.

Figure 15.

The composite cDNA's nucleotide and derived

amino acid sequence of mouse tryptase X.

The numbers on the

right and left sides of the sequence indicate the nucleotide
positions.

The amino acid sequence deduced from the cDNA is

shown in single-letter code above the first nucleotide of
each codon, and are numbered above every tenth residue.
Amino acid residues -29 to -1 represent the
signal/activation peptide.

The amino acid residues which

comprise the catalytic triad (Hisw , Asp91 and Ser194) are
marked with stars.

The solid square labels the substrate-

binding pocket Asp188 residue.

The potential N-linked

glycosylation site, Asn102, is marked with a dot.

The solid

arrow indicates the location of the intron found in clone
plT86.

The putative polyadenylation signal sequence is

underlined.
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signal, ATTAAA, is present 21 bases upstream from the
poly(A) tail.

The open reading frame encoded a peptide of

274 amino acids and terminated at a TGA stop codon.
The nucleotide and derived amino acid sequences of
mouse mast cell tryptase II is given in Figure 16.

The

compiled nucleotide sequence of tryptase II is 986 bp long,
consisting of an open reading frame of 801 bp and a 185 bp
3'-untranslated region.

The presumed polyadenylation

signal, AATAAA, begins 18 nucleotides 5* to the poly(A)
tall.

The two mouse tryptases share 75% and 70% sequence

identities at their nucleotide and amino acid levels,
respectively.

The base composition of the mouse tryptase

cDNAs are high in G and C.

The percentage of overall G + C

content for both mouse tryptase cDNAs is 56%, compared to
41% for average mouse genomic DNA (Arrighi 6t al., 1970).
Both ipouse tryptases I and II contain a short poly (A) * tail
of only 9 bases.

This is consistent with the results of RNA

slot-blot hybridization showing high levels of tryptase RNA
in the low salt fraction, which contained short poly(A)*
tails (see Figure 12).
The apparent functional domains of mouse mast cell
tryptase I and II, like dog tryptase, consist of 245 amino
acid residues.

Each enzyme exhibits all the features

characteristic of a serine protease.

The functional domains

start with the typical Ile-Val-Gly-Gly sequence and have the
active site charge-relay residues His44, Asp91, and Ser194

Figure 16.

Mouse mast cell tryptase IX cDNA's nucleotide

and its derived amino acid sequences.

The amino acid

sequence deduced from the cDNA is shown in single-letter
code above the first nucleotide of each codon, and numbered
above every tenth residue.

Amino acid residues -22 to -1

represent the signal/activation peptide.
notations are the same as in Figure 14.

The labeling and
Notice that the

putative glycosylation site at Asn21 does not exist in mouse
tryptase I.
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corresponding to His57, Asp102 and Ser195 in chymotrypsin.

The

residues surrounding the active sites are highly conserved
in serine protease, which is also true of the mouse
tryptases.
The partial seguence of clone plT86, coding for
tryptase I, is identical to the corresponding regions of
plT4, except that an additional 119 nucleotides are present
within the codon for Pro<B (see figure 15).

This seguence

was not present in any other clone sequenced.

At this

position, three amino acids after the active site His
residue, introns have been found in a group of other serine
proteases, including trypsin (Craik et al., 1984), cytotoxic
cell protein I (Lobe et al., 1988), RMCP II (Benfey et al.,
1987), human neutrophil cathepsin G (Salvesen et al., 1987),
human glandular kallikrein (schedlich et al., 1987) and
human tryptase (Vanderslice et al., 1990).

The total 119 bp

additional nucleotide seguence is shown below:

5'-GTGAGTCTCCCTGGGCCTGGCATGGTGGGACGGGATCTAGATTATTCCCACCATCCC
CAGTGTTCCCGAGGATGTGCCCATCCTGGCTGGAGCTTCTGAGCATGATTATACTCTTCT
AG-3'.

The double- and single-underlined hexanucleotide sequences
at the 5' and 3* termini, respectively, of this region are
consensus sequences for intron/exon splicing junctions
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(Breathnach and chambon, 1981).

This suggests that this

seguence most likely represents an unspliced intron or an
intron remnant.
Neither of the cDNAs for the tryptases were isolated as
full length.

The 5 1 nucleotide sequence of tryptase I did

not contain an ATG codon for a Met residue, which could have
served as a translation initiation signal.

Although an in

frame ATG codon exists in the -5 position in tryptase II, it
is doubtful that it serves as a translation initiation site.
By analogy to the signal peptides of dog and human tryptases
(Vanderslice et al., 1989; Miller et al., 1989), the mouse
tryptases are expected to have signal peptides of 30 amino
acids.

Therefore, the 29 and 22 amino acid peptides at the

5* ends of tryptase I and tryptase II, respectively,
represent partial leader peptide sequences for the mouse
tryptases.

These leader peptides are only 55% identical to

each other with regard to amino acid sequence as compared to
70% identity for the catalytic region.

The nucleotides

coding for the leader peptide sequence of tryptase II are
69% identity with the corresponding sequence of tryptase I.
Molecular Cloning of Mouse Mast Cell Chvmase
Chymotryptic activity in ABFTL-6 cell extracts was
detected at a very low level using the synthetic
chymotryptic substrate Boc~(Ala)2-Pro~Phe-pNA (data not
shown).

However, the ABFTL-6 cell RNA slot-blot probed with

a rat mast cell chymase II (RMCP II) cDNA revealed a high
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Figure 17.

Mouse mast cell RNA slot-blot hybridization

analysis for chymase-encoding sequences.

This RNA slot blot

is the same used for dog tryptase cDNA hybridization as
described in Figure 12.

Hybridization was carried out at

standard stringency with labeled RMCP II cDNA as probe.

(A)

Formaldehyde denatured RNA; (B) NaOH-treated RNA; (c) NaOHtreated mouse genomic DNA.
RNA, respectively.
respectively.

Lane 1 and 2 contain 1 and 3 fig

Row a and b contain 0.4 and 2 fig DNA,

level expression of chymase RNA (Figure 17).

These results

indicate that ABFTL-6 cells may contain significant chymase
activity and that better enzyme substrates are needed for
detecting and measuring this activity.

The strategy used

for cloning mouse chymase cDNA was the same as that employed
for the tryptase cDNA (see Figure 3).

Initial

screening of

the cDNA library was with the insert of RMCP II, which
identified 15 hybridization-positive clones.

Eight of these

were plague-purified and their DNA isolated.

The inserts,

released by EcoRI cleavage, ranged in size between 400 and
600 bp.

Seven clones (/2, 3, 4, 5, 8, 9, and 10) were

subcloned into pTZ19U plasmid for sequence analysis.

The

compiled sequences revealed that the inserts code for a
carboxyl terminal sequence of a novel chymase.

Clone #3

insert DNA was then used as a probe in rescreening the
original cDNA library (1 X 105 recombinant phages).
Hybridization-positive chymase plaques were found at a
frequency of -0.5%, which is similar to that found for the
tryptase cDNA.

Of the 120 partially plaque-purified

positives, nineteen were selected for detailed analysis
based on plaque hybridization intensity.
inserts ranged from 600-1500 bp.

The size of their

Seven of the larger

inserts were subcloned for sequence analysis.

Similar to

the tryptase cDNAs, the sequences obtained fell into two
groups each encoding a previously undescribed mouse mast
cell chymase.

The first group consisted clones plC19, 26,
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and 51.1, and was designated as mouse mast cell chymase I.
The second group included plC51, 127.1, and 102, with
sequences identical to those of the previously isolated
group of chymase clones including plC3.

This second group

was designated as mouse mast cell chymase XI.
Clones pA,C26 and pAci02 are the representatives of
mouse chymase I and II, respectively.

The Hindlll and PstI

restriction fragments of chymase I and the AccI, Rsal and
Hindlll restriction fragments of chymase II were subcloned
for sequencing.

Ninety five percent of the sequence data

were verified by sequencing the complementary strand or
independent recombinants.

The subcloning and sequencing

strategies for these two chymase cDNAs are presented in
Figures 18 and 19.
The consensus nucleotide and the derived amino acid
sequences of mouse chymase I are shown in Figure 20.
Translation starts at an ATG initiation site codon (base 6),
and stops at the TAG stop codon (base 747) in the same
reading frame.

The open reading frame is preceded by 5

bases of a 5' untranslated region.

There are 211

untranslated bases located after the stop codon.

The

translated form of mouse chymase I consists of 247 amino
acids including a characteristic hydrophobic signal peptide
of 21 amino acids.

The mature form of the enzyme contains

226 amino acids with a calculated Mr of 25.4 kd.

Hisw ,

Asp89, and Ser182 of the deduced chymase sequence correspond
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Figure 18.

Strategy for subcloning and sequencing mouse

chymase I cDNAs.
frame of the cDNA.

The rectangle represents the open reading
The hatched and open areas show the

regions encoding the putative signal/activation peptide and
the active chymase, respectively.

The lines attached to

rectangles designate the 5* or 3'-noncoding region.

The

lines with arrows indicate the length and direction of
nucleotide sequences obtained by dideoxnucleotide sequencing
of the cDNAs and their subfragments.
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Strategy for subcloning and sequencing mouse

chymase II cDNAs.

The open rectangle represents the open

reading frame of the cDNA.

The shadowed areas show the

regions encoding for the putative intron sequence.

The

lines attached to rectangles represents the 3'-noncading
region.

The lines with arrows indicate the length and

direction of nucleotide sequences obtained by
dideoxnucleotide sequencing of the cDNAs and their
subfragments.

Notice that the EcoRI site at the 5' end of

the sequence is an internal site.

The nucleotide sequences

of pic 1 through 9 are identical to plC3.

Figure 20.

The composite cDNA's nucleotide and derived

amino acid seguence of mouse mast cell chymase I.

The

numbers on both sides of the sequence indicate nucleotide
positions.

The amino acid sequence deduced from the cDNA is

shown in single-letter code above the first nucleotide of
each codon, and are numbered above every tenth residue.
Amino acid residues -21 to -1 represent the
signal/activation peptide.

The amino acid residues which

comprise the catalytic triad (Hisw , Asp89 and Ser182) are
marked with stars.

The solid square labels the residue

(Asn176) in the substrate-binding pocket.

The potential N-

linked glycosylation site (Asnw ) is marked with a dot.
putative polyadenylation signal sequence is underlined.

The
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to the active-site residues His57, Asp102, and Ser195 in
chymotrypsinogen which are essential for the proteolytic
activity of all serine proteases (Fersht, 1977).

Residue

Asn176 is present in the substrate binding pocket suggesting
an unusual substrate specificity, because this residue has
not been found at this position in other serine proteases.
A potential N-linked glycosylation site is present at amino
acid residue Asn59.

Based on the number of basic (Arg + Lys

= 2 3 ) and acidic (Asp + Glu = 20) amino

acids, the mature

enzyme is positively charged at pH 7.4.
The consensus nucleotide seguence obtained from mouse
chymase II clones consists of 1009 nucleotides and includes
an exceptionally long poly (A)+ tail of 46 bases.

The

seguence contains 227 and 253 bases of 5' and 3*
untranslated regions, respectively.

Amino acid seguence

analysis of the long open reading frame revealed that it
represents the carboxyl terminal of a different chymase
which shares 52% seguence identity with the corresponding
region mouse chymase I.

The nucleotide and derived amino

acid sequences of chymase II are presented in Figure 21.
The protein seguence comprises 175 amino acid residues and
begins at the third exon of most known serine proteases.
Most likely the 5'-end 227 base noncoding region represents
an unspliced intron sequence since there is a highly
conserved intron/exon junction at this location in the
serine protease superfamily (Benfey et al., 1987;

Figure 21.

The consensus nucleotide seguence of mouse mast

cell chymase II cDNA and its derived amino acid seguence.
The numbers on both sides of the seguence indicate the
nucleotide positions.

The amino acid seguence deduced from

the cDNA is shown in single-letter code above the first
nucleotide of each codon, and are numbered above every tenth
residue.

The underlined nucleotides represents the putative

intron seguence.

The active site amino acid residues Asp89

and Ser182 are marked with stars.

The solid square labels

the residue (Ser176) in the substrate-binding pocket.

The

two potential N-linked glycosylation sites (Asn82 and Asn100)
are marked with a dot.

The amino acid residue numbering

follows that for mouse chymase I (Figure 20) under the
assumption that mouse chymases I and II have similar primary
structure.
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Vanderslice et al., 1990).

Introns at this position, 4

amino acid residues after the active site histidine, are
found in all known serine proteases.

In the exact same

position, an intron has been found in one mouse tryptase I
clone, pJLT85 (see Figure 15) ,

Furthermore, a putative

intron/exon junction sequence (TGGAAG) is located at the 3'
end of the proposed intron sequence.
DNA sequence analysis shows that there is no EcoRI/Notl
adopter sequence at the 5' end of the plasmid insert.

This

indicates that the EcoRI site used to subclone this segment
from the original 1C102 cDNA insert is an internal
restriction site within the intron sequence (see Figure 19).
Therefore, this subcloning step eliminated the 5 1 end of
this cDNA from subsequent analysis.
Northern and Southern blot analysis
To study the tissue specific expression of tryptase and
chymase in mouse tissues and mast cells, and to investigate
the size of their primary transcripts, a Northern blot
hybridization analysis was performed as shown in Figure 22.
Poly(A+) RNA from ABFTL-6 mouse mast cells, tongue and
intestine tissues were prepared and blotted onto a Nytran
membrane.

When this blot was probed with a chicken o-

tubulin cDNA as a control hybridization, positive signals
were present in all three samples (Figure 22, panel A).
However, hybridization of the same blot with the plT4/DraI
5' fragment of tryptase I (see Fig. 14) revealed that

A

Figure 22.

B

C

Northern blot hybridization analysis for

tryptase and chymase expression.

Purified poly(A)+ RNA from

mouse tongue (6 fig, lane a), intestine (6 fig, lane b), and
ABFTL-6 mouse mast cells (2.4 fig, lane c) were fractionated
on a formaldehyde-containing 1.5% agarose gel and blotted
onto a nitrocellulose membrane.

The blot was sequentially

hybridized with a chicken a-tubulin (Panel A) , plT4/DraI 5 1
fragment (tryptase I; Panel B), and pAC3 insert DNA (mouse
chymase II; Panel C).

All probes were ^P-labeled by the

random primer method and hybridized to the filter under
standard hybridization conditions.

The size of molecular

weight markers are indicated to the left.

tryptase RNA was detectable only in the mast cells and, at
much lower levels, in the tongue tissue.

No hybridization

was detectable from the intestine RNA (Figure 22, panel B).
Using piC3 insert (chymase II) as a probe, strong
hybridizations were found in both the mast cells and tongue
tissue.

A barely detectable level of chymase hybridization

to the intestine RNA was noticed also (Figure

22, panel c).

Tongue is known as a CTMC-rich tissue, and has been used as
a good source for mast cell chymase isolation (Kido et al.,
1984).

However, tongue also contains many other cell types.

Thus, the intensive hybridization observed in tongue
poly(A)+ RNA indicates that the relative level of chymase
expression in the tongue is extremely high,

chymase

expression is much higher than that of tryptase in tongue
tissue as judged by comparing the tryptase and chymase
hybridization intensities with those of ABFTL-6 poly(A)+
RNA.
The average sizes for tryptase and chymase primary
transcripts, estimated from the Northern blot, are 1250 and
1150 bases, respectively.

This suggests that the cDNA

clones isolated for mouse tryptases and chymases lack a
portion of 5* region.
A Southern blot hybridization analysis was performed to
study mouse tryptase gene structures.

The plT4/DraI 5'

fragment and a mouse tryptase II synthetic oligonucleotide
were used as probes of a mouse genomic DNA blot as shown in

in Figure 23.

These two probes are gene specific for mouse

tryptase I and II, respectively.

Comparison to the dog

tryptase gene structure suggests that these probes should
not contain an intron/exon junction site (Vanderslice et
al., 1990).

The plT4/DraI 5' fragment is 90 bp long,

corresponding to nucleotides from bases 57 to 147 of mouse
tryptase I cDNA (see figure 15).

Although this fragment has

72% sequence identity to mouse tryptase II in the
corresponding region, it will not cross-hybridize to
tryptase II since 83% sequence identity is required for
positive hybridization under the standard conditions.

The

mouse tryptase II oligonucleotide sequence was derived from
base 19 to 45 of mouse tryptase II cDNA and shares 67%
sequence identity to tryptase I in the corresponding region.
As shown in Figure 23, a single band was detected in
each lane, regardless of which restriction enzyme was used.
Moreover, the two mouse tryptase gene-specific probes
exhibited different hybridization patterns.

These results

suggest that each mouse tryptase is probably encoded by a
single gene.
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Figure 23. Southern blot analysis of tryptase genes in
mouse genomic DNA. House genomic DNA (15 fig) was digested
with restriction enzyme and separated on a 1.0% agarose gel.
The gel was stained with EBr to display the fragment
distribution pattern of the total DNA (panel A ) , and the DNA
was blotted onto a Nytran hybridization membrane. The blot
was hybridized sequentially with the [a-32P]-labeled
plT4/Dral 5' fragment of tryptase I under standard
hybridization conditions (panel B) and [y-32P]-5'-endlabeled mouse tryptase II specific oligonucleotide in 3 X
SSPE, 1% SDS and 20% formamide at 42°C (panel C). The size
(kb) and location of molecular weight markers are indicated
to the right of the panels. The restriction enzymes used to
digested the DNA are indicated on the top of each figure.
They are: E, EcoRI; H, Hindlll, K, Kpnl; P, PstI; T, TaqI;
B, BamHI; R, Rsal; X, Xbai; The sequence of neither probe
contains any restriction site for those restriction enzymes
used to digest the mouse genomic DNA.

CHAPTER 4
Discussion

Growth of ABFTL-6 Mouse Mast Cells in FCM
The ABFTL-6 mouse mast cell line used in these studies
was derived from fetal mouse liver in the presence of IL-3
and transformed with Abelson murine leukemia virus (Pierce
et al., 1985).

Although the transformed cells no longer

require IL-3 for growth, they retain other characteristics
of mast cells derived from hemopoietic tissues.

They are

small in size, contain few cytoplasmic granules and a low
level of histamine (Pierce et al., 1985).

They are

considered representative of the MMC in vivo (Katz et al.,
1985; Katz and Austen, 1987).
It has been reported that the viability and the CTMC
phenotype of purified rat peritoneal mast cells and human
lung mast cells could be maintained for prolonged periods in
vitro if the mast cells were co-cultured solely with mouse
3T3 fibroblast cells (Levi-Schaffer et al., 1985; LeviSchaffer et al., 1987a).

Co-culture with 3T3 fibroblasts

also induced in vitro-differentiated. IL-3-dependent mouse
mast cells to change phenotype from mucosal-like to
connective tissue-like mast cells (Dayton et al., 1988;
Levi-Schaffer et al., 1986; 1987b).

More recently, Jarboe

et al. (1989) have identified mast cell-committed progenitor
cells from the mesenteric lymph node of mice infected with
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Nippostroncrvlus brasillensis.

These progenitors are able to

proliferate and differentiate into CTMC-like cells when
cultured on a fibroblast monolayer or in conditioned media,
and into MMC-like cells when cultured in the presence of
ID-3,
The results of this study have shown that cell-free,
3T3 FCH can induce phenotypic change of the ABFTL-6 mast
cells.

No direct contact between fibroblasts and mast cells

was necessary.

The results have also demonstrated that,

like mast cells from other species, these mouse mast cells
contain a tryptase which exhibits an inhibition profile
similar to that of dog and human tryptases (smith et al.,
1984? Caughey et al., 1987; Butterfield et al., 1990).
Also, the mouse tryptase is immunoreactive to human tryptase
antibody suggesting a similarity between their primary
structures.
ABFTL-6 mouse mast cells undergo phenotypic changes
upon culturing in media supplemented with FCM.

The induced

mast cells increased in size, had larger and more
cytoplasmic granules which stained intensely with toluidine
blue, and increased the total cellular protein about four
fold.

FCM induced an increase in tryptase enzymatic

activity in ABFTL-6 cells about 13-fold.

However, immuno

reactive tryptase protein increased by 54-fold.

The induced

cells contained 125 fig tryptase per 106 cells based on
immunoassay using antibodies to human tryptase, which is

much higher than the 35 /ig/106 cells found in human mast
cells from adult foreskin (Schwartz et al., 1987).

Total

DFP-binding proteins were also increased to much higher
levels (Figure 11).

Most interestingly, the ratio of

tryptase to the total cellular protein has increased
dramatically, from 2.7% in uninduced cells to 38% in induced
cells.

This tryptase level in the induced cells is

considerably higher than previously estimated for human lung
mast cells (23%) and for chymase, the predominant neutral
protease in rat mast cells (25%)

(Schwartz et al., 1981a).

At present, the data does not allow a determination of
whether these changes reflect the maturation process or the
further differentiation of ABFTL-6 cells from MMC-like to
CTMC-like. However, the latter possibility is more likely
since the importance of fibroblasts or a connective tissue
micro-environment in the development and maintenance of CTMC
is well established (Galli, 1990).
Several mast cell growth factors have been identified
in recent years.

Survival and growth of in vitro-

differentiated hemopoietic tissue "MMC-like" mast cells
strictly depends on IL-3.

IL-4 acts in synergy with IL-3 in

the proliferation of "MMC-like" mast cells and also appears
to be essential for "CTMC-like" mast cell growth in vitro
(Hamaguchi et al., 1987; Ihle et al., 1983; Nakahata et al.,
1986).

The 3T3 fibroblasts do not produce detectable IL-3

or IL-4 (Fujita et al., 1988).

The nature of the fibroblast

factors involved in the induction of mast cell phenotypic
changes remains to be determined.

However, a soluble factor

in FCM responsible for mast cell-1committed progenitor cell
differentiation and proliferation has been partially
characterized (Jarboe et al., 1989).

It appears to be a

novel cytokine secreted by fibroblasts since its mast cell
proliferation activity could not be mimicked by a wide
variety of other growth factors,

whether this is the same

factor which promoted the observed differentiation of ABFTL6 mouse mast cells is currently unknown.

Recently, a new

hematopoietic growth factor with a broad range of biological
activity has been defined (Witte, 1990).

This growth factor

is known to influence hematopoietic stem cell development,
including those for mast cells.
Sodium_Butvrate_lnduction of Tryptase. Expression
in ABFTL-6 Mouse Mast Cells
Sodium butyrate has been known to increase the
development of cytoplasmic granules and the storage of
granule-associated mediators in mouse mastocytoma cells.

In

the presence of butyrate, histamine content increased
concomitant with cytoplasmic granule maturation and exceeded
that of untreated mast cells by 140-fold (Mori et al.,
1980).

This effect of butyrate has been confirmed in mouse

BMMC (DuBuske et al., 1984).

In addition, butyrate-treated

mast cells increased the cellular levels of [3H] DFP-binding
protein twofold and cytoplasmic granule-associated tryptic
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activity fourfold.

However, variation of the effectiveness

of butyrate induction has been noticed among different
clones of mast cells (Mori et al., 1980).

Sodium butyrate

failed to induce synthesis of heparin in vitro-cultured MMClike mast cells (DuBuske et al., 1984).

This is a major

difference between butyrate and FCM induction.
Sodium butyrate exhibited a tryptase induction effect
on ABFTL-6 mouse mast cells similar to the FCM.

Besides the

morphologic changes, the butyrate-induced cells increased
total cellular protein content three-fold and tryptase
activity six-fold.

Surprisingly, tryptase protein content

measured by immunoassay using antibodies to human tryptase
increased from 2.3 /ig/106 cells to 75 fig/106 cells, a 32fold increase (refer to Table 2 in Results).

The ratio of

tryptase to the total cellular protein increased to 28% from
2.7%.

This result is in agreement with those previously

reported concerning the effect of butyrate on cultured mast
cell granules-associated serine proteases.

However, it also

indicated that tryptase production by ABFTL-6 mast cells was
more sensitive to butyrate induction than that reported by
the BMMC (DuBuske et al., 1984).
While the precise mechanism by which butyrate induced
tryptase synthesis and other phenotype changes is obscure,
it is known that butyrate causes hyperacetylation of histone
protein by inhibiting the deacetylase enzyme (Riggs et al.,
1977; Candido et al., 1978).

This modification of histones
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is coupled with an increased transcription (Allfrey et al.,
1964).

Butyrate can increase methylation of histone, and

increase the activity of cell membrane-bound enzymes
including alkaline phosphatase and adenylate cyclase
(Simmons et al., 1975; Henneberry and Fishman, 1976).
Endogenous Tryptase inhibitor in Hast Cells
Since tryptase is stored and released in its fully
active form, unlike pancreatic proteases, it is a potential
hazard to its host cells.

Thus, it is reasonable to assume

that tryptase activity may be regulated by certain protease
inhibitors which co-exist with tryptase within mast cell
granules.

An endogenous rat serine protease inhibitor,

named trypstatin, has been well characterized and its amino
acid sequence determined (Kido et al., 1985 and 1988).
Trypstatin associates with tryptase in granules of rat
peritoneal mast cells and forms a complex in a molar ratio
of 1:1 with each subunit of tryptase.

Trypstatin strongly

inhibits tryptase and blood coagulation factor Xa.

It also

inhibits porcine pancreatic trypsin and rat chymase (Kido et
al., 1988).

Although one would expect that the expression

of trypstatin may be a universal feature of mast cells, this
type of inhibitor has not been identified in mast cells of
any other species.
Whether there is a trypstatin-like tryptase inhibitor
present in mouse mast cells and how it would be affected by
tryptase-inducing agents are entirely unknown.

However, the

results of our induction experiments revealed that the
increases in tryptic activity and tryptase antigen levels
were not directly proportional.

For example^ while tryptase

antigen increased about 54-fold in FCM induced cells, the
tryptic activity only increased 13-fold.

These results

invite speculation that there may be a tryptase inhibitor in
ABFTL-6 mouse mast cells, and that this inhibitor may be
induced in parallel with the tryptase.

An alternative

explanation may be that FCM or butyrate might induce the
synthesis of proteins that share some antigenicity with
tryptase, but lack proteolytic activity, or have different
substrate specificities.
Trvotase Processing
Both mouse tryptases clearly have leader sequences
which must be removed prior to the generation of active
enzymes with the classic N-terminal sequence Ile-Val-Gly-Gly
found in many serine proteases (Figure 24).

As noted by

Vanderslice et al. (1989), the tryptases are the first
family of proteins to have Gly in the -1 position.

While

the active enzyme could be generated via signal peptidase
cleavage after Gly'1, this is doubtful because there are no
reported instances of signal peptidase cleavage with Arg or
Lys in the -3 position (von Heijne, 1986).

Another possible

signal peptidase cleavage site is Ala'6 which is conserved
in the four known tryptases and is Leu in dog mast cell
protease.

However, this would also result in an Arg residue
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Alignment of leader sequences of the mouse

tryptases and other related proteases.

The proposed sites

for cleavage of the signal and activation peptides are shown
by arrows.

Numbering across the top refers to the leader

peptide sequences, whereas numbering across the bottom
refers to the proposed signal peptide sequences.

(Arg'9) in the -3 position relative to Ala"6 of mouse
tryptase I.

This diminishes the likelihood of Ala'6 being

the processing site.

A more likely site of cleavage is

the -4 position which contains Gin in three of
the sequences, with Thr'* in mouse tryptase II and Pro'* in
dog mast cell protease.

Gin, Thr, and Pro residues have

served as processing sites in eukaryotes and this choice
results in Ala*6 being in the -3 position of all four
tryptases.

Ala is the most favored residue in this position

(von Heijne, 1986).

Dog mast cell protease has a Leu'6 in

the -3 position relative to the proposed signal peptidase
cleavage site, which is not as highly favored as Ala in
the -3 position.

However, this places Ser'5 in the -2

position and Ser is the most favored residue in the -2
position (von Heijne, 1986).

Signal peptidase processing at

the -4 positions in the leader peptide sequences as shown in
Figure 22 would leave zymogens with propeptides of three
residues consisting of Arg-X-Gly, Lys-X-Gly in all cases,
except for Gln-X-Gly in human tryptase.

Although human

tryptase would not have a basic residue for its zymogen form
amino terminus, a polar Gin residue with a charged alpha
amino group would seem to be a plausible substitution at
this position.

A propeptide consisting of only two amino

acids has been found in the leader sequences of the human
neutrophil proteases cathepsin G and elastase (Salvesen et
al., 1987; 1990).

These are granule-associated, active
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enzymes also.

Of course, it is possible that the processing

and activation of the tryptase family involves unique
cleavages and additional studies are needed to clearly
understand these events.
Deduced Trvotase Structures
Analysis of the deduced amino acid sequence of mouse
tryptase 1 revealed that it encoded the entire catalytic
portion of the protease.

The active enzyme consists of 245

amino acids with a calculated molecular weight of 27,395 Da.
A 29 amino acid-long partial leader peptide precedes the
active enzyme.

Tryptase II also contains a catalytic region

of 245 amino acids with a calculated molecular weight of
27,410 Da, and a partial signal peptide of
The lengths of the catalytic

22 amino acids.

region of the mouse

tryptases

are equivalent to that of dog tryptase (Vanderslice et al.,
1989), but they are one amino acid residue longer than human
tryptase (Miller et al., 1989).

The 280 nm extinction

coefficients for 1% protein solutions calculated by the
method of Gill and von Hippel (1989) are 25.1 and 24.2 for
mouse tryptase I and mouse tryptase II, respectively.
tryptase was found to have a

value of 28.1 based

Human

onamino

acid analysis data (Smith et al., 1984).
There is little doubt that these two groups of cDNA
clones code for two distinct mouse mast cell tryptases.
They share extensive sequence identity with the dog and
human tryptases (Figure 25) and their leader peptides end

Figure 25.

comparisons of the amino acid sequences of mouse

tryptase active enzymes with the amino acid sequences of
related proteases.

The residue numbering follows the

standard chymotrypsinogen notation.

A single small dot

represents an amino acid residue at that position identical
to that of mouse tryptase I, and dashes indicate gaps
introduced in order to achieve maximum homology.

Stars

indicate the active site residues His57, Asp102, and Ser195
which compose the catalytic triad.

The putative N-linked

glycosylation sites are underlined, and the Asn linkage
residue is marked with a dot.

The number of residues in

each enzyme is listed at the end of its sequence.

Homology

percentages relative to each mouse tryptase are given in
parentheses.

The sources of the sequence data are as

follows: dog tryptase and dog mast cell protease (DHP)
(Vanderslice et al., 1989), human tryptase (Miller et al.,
1989), bovine trypsin (Hartley, 1970) and bovine
chymotrypsin (Blow et al., 1969).
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with a Gly residue prior to their Ile-Val-Gly-Gly sequences,
as previously noted for mast cell tryptases (Vanderslice et
al., 1989).
A comparison of the derived amino acid sequences of the
active enzyme regions of the mouse tryptases to dog and
human tryptases, dog mast cell protease, trypsin, and
chymotrypsin is shown in Figure 25.

Mouse tryptase I is

most identical to dog tryptase at 74%, while mouse tryptase
II is most identical to human tryptase at 73%.

Mouse

tryptases I and II are 41% identical to bovine trypsin, but
if equivalent residues are considered the homology increases
to 64 and 61%, respectively.

The mouse tryptases are only

distantly related to the proteases present in mouse
cytotoxic T lymphocytes.

For instance, mouse cytotoxic T

cell protease I (Lobe et al., 1988) has only 36% and 35%
sequence similarity to mouse tryptase I and II,
respectively.
Both mouse mast cell tryptases have a potential Nlinked glycosylation site at residue Asn113, the same
location as in dog and human tryptases.

Tryptase II,

however, has an additional putative glycosylation site at
Asn36.

Human skin tryptases also shows differences in

glycosylation.

Human skin tryptases I and II contain two

consensus N-glycosylation sites, whereas skin tryptase III
only has one such site (Vanderslice et al., 1990).
that the tertiary structures of mouse tryptase II

Assuming

approximate the general topography o£ trypsin and
chymotrypsin, both of these glycosylation sites would be
positioned near each other at the top of the molecule when
viewed with the substrate binding pocket facing and
extending down to the right (Dickerson and Geis, 1969).
Such a finding provides additional support for the idea that
tryptase heterogeneity, as seen on SDS-PAGE, is due in part
to the extent of glycosylation (Cromlish et al., 1987).

The

catalytic regions of these two tryptases both begin with
Ile-Val-Gly-Gly and exhibit all of the features
characteristic of serine proteases.

The active site

"charge-relay" residues Hisw , Asp91 and Ser,M, corresponding
to His57, Asp102 and Ser195 in chymotrypsin, are conserved.
The residues surrounding the active sites are highly
conserved in serine proteases, which is also true of the
mouse tryptases.
Eight cysteine residues are found in both tryptases I
and IX, all of which are present in positions identical to
eight of the ten cysteine residues of bovine trypsin.
Presumably, these form disulfide linkages in the same
arrangement as in trypsin.

The absence of two disulfide

linkages in these and other tryptases may result in
decreased stability relative to trypsin.

Interestingly, the

mouse tryptases share the same eight cysteine residues with
human tryptase; whereas, dog tryptase has nine cysteine
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residues.

Dog mast cell protease differs considerably from

the tryptases with twelve cysteine residues.
Trvntase Substrate Specificity Predictions
The mouse tryptases are predicted to have trypsin-like
specificities for Lys or Arg residues in the P., position of
substrates, since an Asp is present in their substrate
binding pocket (residues 188}, corresponding to the
substrate binding pocket Asp189 in trypsin (Figure 26).

The

sidewalls of both mouse tryptase substrate binding pockets
are lined with residues of Asp1B9-Ser190-Cys191-Gln192 and Ser2KTrpzis-Glyz16 (chymotrypsinogen numbering system), an
identical situation to that of dog tryptase and trypsin.

In

contrast, human tryptase has a Lys residue in position 192
and an Asp instead of a Gly in position 216.

Thus, the

substrate specificities of the mouse tryptases may be in
closer agreement with those of dog tryptase (or bovine
trypsin) and may differ from the rather unusual
specificities of the human skin and lung tryptases (Tanaka
et al., 1983).

Interestingly, residues in position 99 based

on the chymotrypsin numbering system are Gly for tryptase I
and Asp for tryptase II.

This position influences substrate

specificity with regard to the amino acid in position P2.
The differences at position 99 in the mouse tryptases
suggest substrate specificity differences with respect to
substrate specificity.

An interesting feature of mouse

tryptase I is that the lie103 in the highly conserved region

101
around active site Asp102 is substituted by an equivalent
amino acid Val103 (tryptase residue 92) in mouse tryptase I.
While this substitution may not affect the enzyme's tertiary
structure or function, Val in this position has never been
observed in other members of the serine protease family.
Charged Residues of Tryptase
Mouse tryptase I is predicted to have a net charge of
-5 at neutral pH, since it contains 23 acidic residues (Asp
+ Glu) but only 18 basic residues (Arg + Lys).
Surprisingly, tryptase II is much more negatively charged
than tryptase I, with a net negative charge of -10 at
neutral pH (Asp + Glu *= 25, Arg + Lys

15).

The estimated

isoelectric points for mouse tryptases I and II are 6.2 and
5.6, respectively.

The charges on human and dog tryptases

are -4 and -3, respectively, which are in closer agreement
with mouse tryptase I than with mouse tryptase II.

Thus,

the tryptases are acidic proteins in contrast to the much
more basic trypsin and chymotrypsin molecules with net
charges of +3 and isoelectric points above 9.

These charge

differences probably account for the loss of activity noted
with human tryptase at low pH (Smith et al., 1984); whereas,
trypsin and chymotrypsin are quite stable at low pH.
Human tryptase activity is stabilized by heparin
glycosaminoglycan (Smith and Johnson, 1984) and in the
absence of heparin, tryptase subunits dissociate into
inactive monomers (Schwartz and Bradford, 1986).

Since the

Figure 26.

Analysis of the distribution of charged

residues that are conserved in tryptases.
clusters are predicted.

Two charged

Near the top face of the molecule

is a closely-associated, positively-charged cluster
consisting of residues Lys26, Arg34, and Arg70 (shown in red) .
Another cluster comprised of negatively charged residues
Glu164, Asp169, and Asp177, forms a large patch along the lower
face of the enzyme (shown in yellow).

The active site

residues His57, Asp102, and Ser159 are shown in green.
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interactions necessary for the formation of a tetramer may
rely on the distribution of charge on the surface of the
molecules, charged residues conserved among tryptases have
been examined based on the tertiary structure of
i

chymotrypsin (Dickerson and Geis, 1969).

Twelve charged

residues (five positive and seven negative) are found to be
conserved within the four tryptases shown in Figure 25, but
are not found in the corresponding position of bovine
trypsin.

Assuming a folding pattern similar to that of

chymotrypsin two charged clusters are predicted (Dickerson
and Geis, 1969) as shown in Figure 27.

One near the top

face of the molecule is a closely-associated, positivelycharged cluster consisting of residues 26, 34, and 70.

The

other, comprised of negatively charged residues 164, 169,
and 177, forms a large patch along the lower side of the
enzyme.

Most of these charged residues seem to be displayed

on the surface of the molecules.

Of course, such charge

distributions will require x-ray diffraction analysis for
conformation, but these charges may be involved in the
interactions among tryptase subunits or between tryptase and
heparin.
Interestingly, charge-switching of residues between
mouse tryptase I and mouse tryptase II is observed in four
positions.

Glu residues in positions 75, 107, and 244, in

mouse tryptase I are substituted by oppositely charged Lys
residues in mouse tryptase II, and Lys residue 204 of mouse
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tryptase I is substituted by a negatively charged Glu in
mouse tryptase II.

The charge switching also occurs between

tryptases and other serine proteases such as trypsin.

For

example, Lys60 of trypsin, which is believed to form a salt
bridge with Asp1 of soybean trypsin inhibitor in the
trypsin-inhibitor complex (Sweet et al., 1974), is
substituted with Gly in dog tryptase and mouse tryptases.
This may be one of the reasons why tryptases are resistant
to inhibition by soybean trypsin inhibitor (Vanderslice et
al., 1989).
An unusual charge switching between tryptases and
pancreatic serine proteases such as trypsin and chymotrypsin
occurs at position 169.

Lys residue is present at position

169 in trypsin and chymotrypsin, while an oppositely charged
Asp is found in the identical location in all known
tryptases.

This significant charge difference may

contribute to the unique biochemical properties of tryptase,
such as resistance to inhibition by a-l-FI and selectivity
for natural substrates.

Further investigation is needed to

understand the significance of this charge-switching.
Characterization of the Predicted Protein structures
of Mouse Mast Cell Chvmases
All .of the active enzymes of the chymase class start
with residues Ile-Ile-Gly-Gly.

Thus, the 21 amino acids

prior to this sequence in mouse mast cell chymase I is
expected to be a complete leader peptide.

This is supported

105

twin
2r •

MI
■

<
I

m.B
l
i■*11
M
MB
B■
1
atm

■'
I
■
□
■

tL
It
,l
1
L.
i
lHI
I ii^m

i.......
i
1

fI•

*
i*
-- ---------Jr
£4
12B

.101

241

3*

Figure 27.

Hydrophobicity analysis of mouse mast cell

chymase I.

Hydrophobicity analysis was performed by the

Hopp and Woods method (1981), using the Hitachi PROSIS
protein analysis program.

Each amino acid is assigned a

numerical hydrophobicity value.

The more hydrophobic an

amino acid is, the more negative its value.

The x-axis

indicates the position of amino acid in the protein
sequence.

The y-axis represents the hydrophobicity index

ranging from 2 to -2.

The full length of mouse chymase I is

247 amino acid residues, including a 21 amino acid leader
peptide.
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leader sequence----21
-3
-1 +1
!
|
| j
MHLLTLHLLLLLLGSSTKA
GE
IIGG*«
M. Chymase I
MHCLPLTLLLLLLCSRAEA
EE IIGG*«
Dog Chymase
MQALLFLMALLLPSGAGA
EE IIGG»*
MMCP XI
RMCP II
MQALLFLMALLLPSGAGA
EE IIGG»«
MQPLLLLLAFLLPTGAEA
GE IIGG««
H. Cat. G
H. Elastase
MTLGRRLACLPLACVLPALLLGGTALA
SE IVGG»«
MPPVLILLTLLLPLRAGA
EE IIGG»«
M. Granzyme C
M. Granzyme G
MPPILILLTLLLPLRAGA
EE IIGG»*
Mouse CCP I
MKILLLLLTLSLASRTKA
GE IIGG**
MPPVLILLTLLLPLRAGA
EE IIGG*»
Mouse CCP II
I
i
-18
-1
•signal------ t-pro-t-active-

Figure 28.

Comparison of the mouse chymase I leader

sequence with those of other known chymases and granuleassociated serine proteases.

Numbering across the top

refers to the leader peptide sequences, and numbering across
the bottom indicates the signal/activation sequence.

The

source of the sequence data is as follows: dog chymase
(Caughey et al., 1990)? MMCP II (Serafin et al., 1990); RMCP
II (Benfey et al., 1987); human cathepsin G (Salvesen et
al., 1987); human elastase (Takahashi et al., 1988); mouse
granzyme c (Jenne and Tschopp, 1988); mouse granzyme G
(Jenne et al., 1989); mouse CCP-I and CCP-II (Lobe et al.,
1988).

The abbreviations used are: M, mouse? H, human; cat.

G, cathepsin G; CCP, cytotoxic cell protease.
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by the amino acid hydrophobicity analysis.

As shown in

Figure 27, a large hydrophobic domain is present within that
leader sequence.

The length of this leader peptide is

identical to that of dog chymase, but one amino acid longer
than that of MMCP II, RMCP II, and other granule-associated
serine proteases listed in Figure 28.

As shown in this

figure, the leader sequence of mouse chymase I contains many
features common to those enzymes, and has 57% sequence
identity to that of dog chymase.
Based on the "-3, -I1' rule of von Heijne (1986), it is
predicted that the signal peptidase cleavage site for mouse
chymase I signal peptide would be between Ala*3~Gly*2, since
Ala is the most favored residue in -1 position for peptidase
cleavage.

After removal of the signal peptide, mouse

chymase I exists as a zymogen form containing a "pro"
peptide of two amino acids (Gly-Glu).

This predicted

preprosequence is very similar for all the known chymases,
human cathepsin G, elastase and mouse lymphocyte granule
serine proteases (granzymes) listed in Figure 26.

The

highly conserved residues Glu‘z and Ala*5 within the leader
sequence were replaced with Gly*z and Thr*5 in mouse chymase
I, respectively.

However, Gly in -2 position is also found

in human cathepsin G and mouse cytotoxic cell protease (CCP)
I.

Threonine, a preferred residue in -5 position for

cleavage, is located at the identical position in mouse CCP
II.

Recently, the existence of a dipeptide prosequence in
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human cathepsin G and elastase has been demonstrated by
biosynthetic radio-labeling and radio-sequencing techniques
(Salvesen and Enghild, 1990).

The "pro" peptide is possibly

removed during the packaging of the enzyme.

The similarity

between the potential preprosequences among these enzymes
indicates that they may share a common activation mechanism.
The mature active enzyme of mouse chymase I consists of
226 amino acids with a calculated Mr. of 25.4 k d r identical
to that of dog chymase and MMCP-1 but two amino acids longer
than MMCP-2.

Sequence analysis reveals that mouse chymase I

contains many characteristic features of a chymotrypsin-like
enzyme, including the Ile-Ile-Gly-Gly amino terminal
sequence and the residues comprising the catalytic "chargerelay" system (His, Asp and Ser) with their highly conserved
adjacent sequences.
An interesting feature of mouse chymase I is that an
Asn residue occurs in position 189 of the substrate binding
pocket, rather than a Ser which is typically present in the
substrate binding site of chymotryptic enzymes with
substrate preferences for aromatic amino acids in the Pt
position.

In the corresponding position of MMCP-1 and

RMCP—II Thr and Ala were found, respectively, Asn at
position 189 has not been previously identified in another
serine protease.

Asn molecule is larger than Ser, and

contains a terminal amide group rather than a hydroxyl
group.

How such substitution affects substrate preferences
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of the chymases enzyme is unknown.

However, it has been

shown that mutant trypsin with Ser189 or Lys189 has an altered
substrate specificity and catalytic efficiency (Graf et al.,
1988).
Moreover, the size of the substrate binding pocket of
mouse chymase I differs from those found in pancreatic
chymotrypsin and trypsin, and most of the mast cell granuleassociated proteases.

The size of the pocket is related to

residues 216 and 226 which form the neck of the binding
pocket.

Gly residues are present at these positions in both

chymotrypsin and trypsin.

This small amino acid permits the

pockets to accommodate large aromatic amino acids in
chymotrypsin, or Arg and Lys residues in trypsin.

This

feature is conserved in both mouse tryptase I and II (see
Figure 26).

However, Gly216 is replaced by a much bulkier

residue Val in mouse chymase I.

A similar substitution at

this position is also found in MMCP II.

Gly226 is replaced

by a sightly larger residue Ala in mouse chymase I, which is
consistent with other mast cell chymases (see Figure 29).
These changes in mouse chymase I presumably will make the
substrate binding pocket much smaller.

The combined effects

of the alterations of ‘the substrate binding pocket of mouse
chymase I require biochemical characterization of the
purified enzyme.

However, very low chymotryptic activity

was found in the lysate of these cells as assayed with
common synthetic chymotrypsin substrates, suggesting that
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the typical chymotryptic substrate-binding specificity is
altered.

A better substrate and purification of the enzyme

may be required for testing and measuring whether mouse
chymase I truly has an unusual substrate specificity.

Mouse

chymase I is a basic protein with a net charge of +13 at
neutral pH, which is comparable to dog chymase (+16) and
RMCP I (+18).

In contrast, the MMC-derived RMCP II and

MMCP-1 have net charges of +3 and +4 at physiological pH.
The derived partial amino acid sequence of mouse
chymase II consists of 175 amino acids with a novel COOHterminal.

It starts at the position corresponding to

residue 50 of mouse chymase I and contains active site
residues Asp and Ser.

A Ser residue occurs in the

substrate-binding pocket in agreement with a chymotryptic
specificity.

One of the major differences between the two

mouse chymase primary structures is that chymase I contains
only one potential glycosylation site (Asn59), whereas
chymase II has at least two such sequences (Asn82 and Asn100) .
A sequence comparison between mouse chymases I and II
with that of other chymases and bovine chymotrypsin is shown
in Figure 27.

Surprisingly, mouse chymases I and II only

share 52% sequence identity, with 54% and 57% sequence
homology to MMCP-I, respectively.

This contrasts with the

two tryptases cloned from these cells which shared 70%
sequence identity.

Mouse chymase I has its highest sequence

similarity (72%) to dog chymase, suggesting that they may be

Figure 29.

Primary structure alignments between the active

enzyme portions of the mouse chymases, other known chymases,
and bovine chymotrypsin.

The residue numbering follows the

standard chymotrypsinogen notation.

A single small dot

represents an identical amino acid residue at that position
to that of mouse chymase I; gaps are introduced as dashes in
order to achieve the maximal homology,

stars indicate the

active site residues His57, Asp102, and Ser195 which compose
the catalytic triad.

The putative N-linked glycosylation

sites are underlined and its Asn is marked with a dot.

The'**'

number of residues in each enzyme are listed at the COOH end
of its sequence.

Identity percentages relative to each

mouse tryptase are given in parentheses.

The sources of the

sequence data are as follow: mouse chymases I and II (this
study), MMCP I (Le Trong et al., 1989), MMCP II (Serafin et
al., 1990), RMCP I (Le Trong et al., 1987), RMCP II (Benfey
et al., 1987), dog chymase (caughey et al., 1990), and
bovine chymotrypsin (Blow et al., 1969).
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analogues In different species.

Mouse chymase II has its

highest homology (68%) with MMCP-II in the corresponding
region.
There are seven cysteine residues located in mouse
chymase I.

Six of them occur at the identical position as

in other known chymases and six of the nine cystienes of
chymotrypsin.

These may form disulfide bridges in the same

pattern as in chymotrypsin, suggesting a conservation of the
general tertiary structure among this enzyme superfamily.
However, analysis of the three-dimensional structure of RMCP
II, revealed a lack of the one disulfide bond near the
active site seryl residue (Cys'l9t to cys*220 in chymotrypsin).
This unique structural feature of the mast cell chymases may
account for their distinctive substrate preferences (Le
Trong, 1989).
Genomic Structure of Mouse Protease Genes
The mammalian serine protease superfamily is believed
to be derived from a common ancestor by gene duplication
during divergent evolution.

The finding of an intron in

both mouse tryptase and chymase in the position
corresponding to a known intron in this gene superfamily
*

suggests that the conserved organization and structure of
the serine protease gene family extends to the mouse serine
protease gene(s).
The mouse DNA Southern blot analysis revealed that only
one genomic DNA restriction enzyme fragment hybridized to

,.

1X3

mouse tryptase I- or II-specific probes regardless of which
enzyme was used to digest the genomic DNA.

This result

indicates that both probes hybridize to only a single locus
in the mouse genome, suggesting that there is only one mouse
gene for each mast cell tryptase.

Mouse tryptases I and II

seem to be encoded by different genes.

These are located at

separate loci because each tryptase gene-specific probe
displayed a distinct hybridization pattern.

A similar

result was observed with rat chymases RMCP I and II which
are encoded by separate genes (Benfey et al., 1987).
Distribution and Expression of Tryptase and Chvmase
in

Mouse Mast Cells

Although mast cell differentiation and development is
not fully understood, two different types of mast cells have
been noted in mammalian species (reviewed in Stevens et al.,
1986).

Rat and human mast cell subpopulations carry

different combinations of proteases.

In rat, CTMC and MMC

contain the distinct chymases RMCP I and RMCP II,
respectively (Woodbury et al., 1978).

Rat connective tissue

mast cells also contain tryptase (Kido et al., 1985), but
structural variants of this rat enzyme are not known.

In

humans both TC and T mast cell types contain tryptase,
whereas only the TC mast cells contain detectable amounts of
chymase (Irani et al., 1986).
The expression pattern of serine proteases in different
subpopulations of mouse mast cells seems much more

complicated than in the rat and human.

To date, six

different serine proteases have been identified in mouse
mast cells.

However, their distribution in MMC and CTMC is

still unknown.

Two chymases, MMCP-1 and MMCP-2, were well

characterized and shown to be selectively expressed in
different MMC populations (Serafin et al., 1990; Le Trong et
al., 1989}.

In addition, three distinct chymases (MMCP-3,

MMCP-4 and MMCP-5) and a putative tryptase (MMCP-6) were
identified in mouse serosal mast cells, representatives of
CTMC, and their amino terminal sequences were determined
(Reynolds et al., 1990).

By comparing their limited amino-

terminal amino acid sequences with that derived from our
tryptase and chymase clones, it seems likely that mouse
tryptase I is identical to MMCP-6, and mouse chymase I is
the analogue of MMCP-5.

Since mouse chymase II lacks the

amino-terminal sequence, it remains to be determined whether
mouse chymase II is a novel protease of mouse mast cells.
In contrast, mouse tryptase II has not been previously
described.

Thus, different mouse mast cell subpopulations

can express at least seven distinct serine proteases in
different combinations.
Both MMCP-6 (mouse tryptase I) and MMCP-5 (mouse
chymase I) are granular constituents of mouse CTMC (Reynolds
et al., 1990).

This is consistent with our Northern blot

hybridization results since both tryptase and chymase
expressions were detected in mouse tongue.

Tongue tissue

has been a good source of rat CTMC for enzyme purifications
(Kido et al., 1984).

In contrast, a barely detectable level

of chymase was observed in the intestine which contains
mainly MMC.

The relationship of the two cloned mouse mast

cell tryptases and the two cloned chymases to particular
mast cell types can not be addressed at present.

It is

possible that a well-differentiated mast cell line can
express proteases of both CTMC and MMC,

The Kirsten sarcoma

virus-immortalized mast cell line contained three of the
CTMC- and one MMC-derived serine proteases (Reynolds et al.,
1990).

Unfortunately, the in vivo-differentiated mouse MMC

has not been successfully purified; no direct comparison
between these culture- and in vivo-derlved mast cells has
been possible.

Mast cell studies still largely rely on

immunohistochemical techniques which may limit our knowledge
of mast cell diversity.
The two mouse tryptases appear to be expressed at a
high level in the ABFTL-6 mast cell line, based on 0.5%
positive plagues in the cDNA library and the isolation of
four clones for each tryptase type.

At present, we can only

speculate concerning the finding of two different tryptases
in ABFTL-6 mast cells*

The cloning of the two enzymes in an

apparently equal ratio suggests that mouse tryptase I and
mouse tryptase II may comprise different subunits of an
active tryptase tetramer, as for human tryptase (Schwartz et
al., 1981a; Smith et al., 1984).

A second possibility is

that the ABFTL-6 mast cells might be stuck at an
intermediate stage in mast cell differentiation, displaying
phenotypes of both immature and mature MMC.

Another

possibility is that viral transformation has resulted in the
expression of tryptases representative of mucosal and
connective tissue mast cells.

Finally, both mouse tryptases

may have diverged from a common ancestor during evolution
for carrying out different biological functions.
Clarification of these issues will reguire additional
studies including the isolation and characterization of each
active enzyme.
The structural information presented provides a sound
basis for future work on these clearly different mouse
tryptases and will aid in our understanding of mast cell
function.
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Buffers and Solutions
Alkaline lysis solution
0.2 N NaOH, 1% SDS {make fresh)
Antibody solution
Tris-Saline containing 0.05% Tween-20, 1% BSA
Bradford reagent
0.01% (w/v) Coomassie Brilliant Blue G-250, 4.7%
ethanol, and 8.5% phosphoric acid
CIA
chloroform/isoamyl alcohol (24:1 v/v)
GTC buffer
5.5 M GTC, 25 mM sodium citrate, 0.5% sodium
lauryl sarcosine, pH 7.0, add B-mercaptoethanol
to 0.2 M immediately prior to use
Kinasing buffer
40 mM Tris-HCl pH 7.6, 20 mM MgCl2, 10 mM DTT,
0.2 mM spermidine, loo /ig/ml BSA, 0.2 mM EDTA
LB broth
10 g bactotryptone, 5 g bacto-yeast extract, 5 g
NaCl, add dH20 to 1 liter, autoclave to
sterilize
Ligation buffer
50 rnM Tris-HCl pH 7.4, 10 mM MgClj, 10 mM DTT,
0.5 mM ATP, 0.1 mg/ml BSA
Loading Buffer
20 mM Tris-HCl pH 7.6, 0.5 M LiCl, 1 mM EDTA,
0.1 % sodium lauryl sarcosinate
M9 salt (10 X)
60 g NajHPOj, 30 g KHjHPO.,, 50 g NaCl, 100 g
NH4C1, add dHjO to 1 liter, autoclave to
sterilize
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Minimal medium
100 ml 10 X M9 salt, 10 ml 20% glucose, 0.1 ml
1% thiamine solution, 1.0 ml 0.1 M CaCl1# 2.0 ml
1 M MgS04, add dH20 to 1 liter
NZY broth
5 g NaCl, 2 g MgS04, 5 g yeast extract, 10 g NZ
Amine (Casein hydrolysate), add dH20 to l liter,
autoclave to sterilize
PEG solution
27% PEG

(W/V)

8000 in 3.3 M NaCl

PBS
0.14 M NaCl, 50 mM sodium phosphate, pH 7.4
Prehybridization solution
3 X SSC (or SSPE), 10 mM Tris-HCl (pH 7.4), 1%
dried non-fat milk, 0.1% SDS, 50% formamide
Protein sample buffer (8 ml)
4.7 ml dHjO, 1.0 ml 0.5 M Tris-HCl pH 6.8, 1.0
ml glycerol, 1.0 ml 10% SDS, 0.1 ml Bmercaptoethanol, 0.2 ml 0.05% bromophenol blue
Protein staining solution
500 ml 95% ethanol, 100 ml acetic acid, 400 ml
HjO, and 2.0 g Coomassie brilliant blue, add dHjO
to 1 liter
R N clS6

A
20,000 U/ml in 10 mM Tris-HCl pH 7.5, 15 mM
NaCl, boiled for 15 minutes
#

Seguenase buffer
40 mM Tris-HCl pH 7.5, 20 mM MgCl2/ 50 mM NaCl.
Sequencing stop buffer
80% deionized formamide, 10 mM NaOH, 1 mM EDTA
0.1% xylene cyanol, 0.1% bromophenol blue
SET solution
20% sucrose, 50 mM Tris-HCl pH 8.0, 50 mM EDTA
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SM buffer
20 mM Tris-HCl pH 7.4, 10 mM MgS04, 100 mM NaCl,
0.01% gelatin
SOG loading buffer
60% sucrose, 0.1% Orange G
SSC (IX)
0.15 M NaCl, 15 mM sodium citrate, pH 7.0
SSPE (IX)
0.18 M NaCl, 10 mM NaP04, 1 mM EDTA, pH 7.7
Ti0E,
10 mM Tris-HCl pH 8.4, 1 mM EDTA
T,E,
1* 0.1
1 mM Tris-HCl pH 8.4, 0.1 mM EDTA
TAE
50 mM Tris pH 8.4, 40 mM acetic acid, 1 mM EDTA
TB broth
5 g NaCl, 10 g Bactotryptone, add dH20 to 1
liter, autoclave to sterilize
THE
50 mM Tris pH 8.3, 50 mM boric acid, 1.25 mM
EDTA
TBS
50 mM Tris-HCl pH 8.0, 150 mM NaCl

APPENDIX B

Restriction Enzymes, Recognition Sequences and Buffers

Enzyme

Cleavage

EcoRX

GAATTC

100 Mm Tris-HCl, pH 7.2, 50 mM NaCl, 5 mM MgCl2

Hinfl

GAANTC

6 mM Tris-HCl, pH 7.5, 50 mM NaCl, 6 mM MgCl2

Pstl

CTGCAG

20 mM Tris-HCl, pH 7.4, 10 mM MgClj, 50 mM(NH4)S04

Not I

GCGGCCGC

3 mM Tris-HCl, pH 7.4, 150 mM NaCl, 6 mM MgCl2

Dra I

TTTAAA

6 mM Tris-HCl, pH 7.6, 50 mM NaCl, 6 mM MgCl2

BamHI

GGATCC

20 mM Tris-HCl, pH 7.4, 100 mM NaCl, 7 mM MgCl2

Sau3AI

GATC

10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 7 mM MgCl2

Kpnl

GGTACC

6 mM Tris-HCl, pH 7.5, 6 mM NaCl, 6 mM MgCl2

HindiII

AAGCTT

50 mM Tris-HCl, pH 8.0, 50 mM NaCl, 10 mM MgCl2

Restriction Endonuclease Buffer*’1

*A11 restriction digestion mixtures contained 6 mM B-Mercaptoethanol and 100 /ig/ml
acetylated BSA (nuclease free).
bLSS restriction enzyme buffer: 20 mM Tris-HCl pH 7.4, 0.05 mM spermine, 0.125 mM
spermidine, 20 mM KCl, 70 mM NaCl, 10 mM MgCl2 (This buffer was used for multi-digestion
reactions since it works for many enzymes including EcoRI, BamHI, Hinfl, Mbol, Hindlll,
Kpnl, HaelX, Haelll, Mspl, TaqI, Rsal, Sau3A, Sail, Smal, and SacI).
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